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High rates of combat exposure exist among veterans of the recent conflicts, and 
are associated with debilitating mental health conditions, including posttraumatic stress 
disorder (PTSD).  Numerous psychosocial and biologic factors are associated with PTSD, 
including the HPA-axis.  The present study aimed to compare baseline neuroendocrine 
levels by trauma group (PTSD, trauma exposed [TE], and non-trauma controls [NTC]) 
among a sample of young veterans.  An exploratory aim was to examine potential 
moderators of the relation between PTSD and basal cortisol/ACTH.  Group differences in 
cortisol were nominally significant, with the NTC group having significantly higher 
cortisol than the PTSD group.  Sleep disturbance was the only moderator of this 
relationship in cortisol, although lifetime trauma load significantly predicted basal 
cortisol across all models.  No significant effects were demonstrated for ACTH.  
		
Examining effects of trauma on basal physiology provides a critical stepping ground for 
future investigations that may inform targeted prevention and intervention efforts.
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Examination of Basal Neuroendocrine Levels in OIF/OEF/OND Veterans 
 
 
 
Trauma exposure is extremely common in both civilian and veteran populations (e.g., 
Breslau et al., 1998; Hoge et al., 2004).  Epidemiological studies have shown that trauma 
exposure is linked to increased risk for posttraumatic stress disorder (PTSD) and other mental 
health disorders (PTSD; Amstadter, Aggen, Knudsen, Reichborn-Kjennerud, & Kendler, 2013; 
Pietrzak, Goldstein, Southwick, & Grant, 2011).  The hypothalamic-pituitary-adrenal (HPA) axis 
plays an essential role in the body’s neuroendocrine response to stress and trauma.  It functions to 
restore homeostasis by means of a negative feedback loop, wherein high levels of 
adrenocorticotropic hormone (ACTH), released in response to stress, signal the termination of 
cortisol production (Handwerger, 2009).  The role of these neuroendocrine markers in PTSD has 
been extensively reviewed in both civilian and veteran populations with PTSD (e.g., Golier, 
Caramanica, & Yehuda, 2012; Horn, Pietrzak, Corsi-Travali, & Neumeister, 2014; Yehuda, 
Southwick, & Krystal, 1993).  However, the majority of studies have examined neuroendocrine 
reactivity, as opposed to baseline levels, which may more accurately depict negative feedback 
loop functioning in trauma exposed and PTSD populations.  Furthermore, although several 
studies have investigated neuroendocrine levels in combat veterans, few have investigated these 
relationships in service members of the recent conflicts in Iraq and Afghanistan. Veterans are a 
unique group in need of study, as increasing numbers of men and women return from the current 
conflicts endorsing high rates of combat-related traumatic events and subsequent mental health 
outcomes (Hoge, Auchterlonie, & Milliken, 2006; Hoge et al., 2004).  In a recent meta-analysis 
examining the prevalence of PTSD in OIF/OEF veterans, Fulton and colleagues (2015) estimated 
that as many 23% of returning service members had PTSD.   
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Following, the present study aimed to compare baseline neuroendocrine levels by trauma 
group (PTSD, trauma exposed [TE], non-trauma controls [NTC]) among a sample of Operation 
Iraqi Freedom/Operation Enduring Freedom/Operation New Dawn (OIF/OEF/OND) veterans.  A 
second, exploratory aim of this study was to examine factors (i.e., social support, sleep 
disturbance, and trauma load) that may moderate the relationship between trauma group and basal 
neuroendocrine levels. In the upcoming sections, trauma prevalence and related mental health 
outcomes are discussed for both civilian and veteran populations, with a focus on PTSD, which is 
the signature trauma-related mental health disorder.  Psychosocial and biological correlates of 
PTSD within these populations are also reviewed, with special emphasis on social support, sleep 
disturbance, and trauma load, given their particularly robust effects on the measured outcomes.  
Next, an overview of HPA-axis functioning and its relationship to trauma exposure is provided, 
followed by an extensive review of the literature on basal cortisol and ACTH functioning in both 
civilians and veterans.  Lastly, aims and hypotheses are presented for the present study.  
 
Trauma Prevalence 
Epidemiological studies suggest that upwards of approximately 90% of individuals in the 
United States will experience at least one traumatic event throughout the course of their lifetime, 
and that a majority of individuals experience multiple traumatic events, averaging as high as five 
reported traumatic events per person (Breslau et al., 1998).  Findings from other widely cited 
nationally representative samples suggest lower lifetime prevalence of trauma exposure, with 
rates ranging from approximately 50% for women to 60% for men (Kessler, Sonnega, Bromet, 
Hughes, & Nelson, 1995).  Lifetime prevalence rates vary depending on trauma type, ranging 
from sudden loss of a close relative or friend experienced by 60% individuals, while the lifetime 
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prevalence rates of military combat exposure reported by less than 2% of individuals (Breslau et 
al., 1998).  These rates are intuitive when considering population proportions (e.g., whereas 
anyone in the population has the potential to experience the sudden loss of a close one, only a 
small percentage of the population will be in environments where exposure to combat trauma is 
possible).   
Sociodemographic factors play an influential role in exposure to traumatic events.  For 
example, lifetime prevalence of the majority of traumatic events is slightly higher in men than 
women (Perkonigg, Kessler, Storz, & Wittchen, 2000).  Men are significantly more likely to 
experience trauma types including witnessing a death or injury, natural disaster, life-threatening 
accident, physical assault, combat experience, threat with a weapon, and captivity (Kessler et al., 
1995).  Moreover, men are approximately twice as likely as women to be exposed to forms of 
physical assaultive violence (e.g., mugging, threat with a weapon, shot or stabbed, severely 
injured in a fight), whereas women are approximately three times more likely than men to report 
rape and sexual violence (Breslau et al., 1998; Frans, Rimmö, Åberg, & Fredrikson, 2005; 
Kessler et al., 1995).  Minority racial status, low education, low income, central-city location, and 
prior marriage have been found to increase the likelihood of experiencing an assaultive traumatic 
event by two fold (Breslau et al., 1998).  Ethnicity is an inconsistent predictor of assaultive 
violence prevalence, such that some studies indicate an increased risk for exposure among 
Caucasians (Burnam et al., 1988; Cottler, Compton, Mager, Spitznagel, & Janca, 1992; Norris, 
1992), while others demonstrate an increased risk among African Americans (Hanson, Kilpatrick, 
Freedy, & Saunders, 1995; Kilpatrick, Seymour, & Boyle, 1991), and still others have failed to 
find any relation between assault risk and ethnicity altogether (Bachman & Saltzman, 1994; 
Breslau, Davis, Andreski, & Peterson, 1991).  Additionally, higher years of education has been 
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found to significantly lower the likelihood of exposure to interpersonal types of trauma within a 
national European sample (Amstadter et al., 2013).  Age has also been shown to play an 
important role in trauma exposure, as demonstrated by a drastic increase in prevalence between 
the ages of 16 and 20 across trauma types, suggesting late adolescence/early adulthood may be a 
critical risk period for trauma exposure (Breslau et al., 1998). Furthermore, previous exposure to 
trauma is associated with increased risk for revictimization (Fleming, Mullen, Sibthorpe, & 
Bammer, 1999; Gidycz, Coble, Latham, & Layman, 1993; Hanson, Kilpatrick, Falsetti, & 
Resnick, 1997; Walker & Lenore, 2009; Zawitz, 1988). 
 Considering the alarming rates of trauma found in civilian populations, attention should be 
given to rates of exposure within military populations, as these individuals are more disposed to 
experience traumatic events due to the nature of their of their combat experiences and deployment 
environments.  Hoge and colleagues (Hoge et al., 2006; Hoge et al., 2004) conducted a national 
survey of veterans who served in Operation Enduring Freedom/Operation Iraqi 
Freedom/Operation New Dawn (OEF/OIF/OND) and found high rates of combat related exposure 
(58-95% had been ambushed or attacked, 84-92% had received artillery fire, 66-97% had been 
shot at, and 25-50% felt in grave danger).  Notably, military personnel are first civilians before 
they enter into the service.  Thus, these individuals have the potential to be exposed to both 
civilian and military traumatic events, potentially increasing the likelihood of experiencing the 
cumulative effects of multiple traumas.  For example, Clancy and colleagues (2006) examined 
archival data from the medical records of over 400 male veterans diagnosed with PTSD and 
found that upwards of 90% had endorsed nonmilitary-related trauma (19% met the diagnostic 
criteria for a trauma for natural disaster prior to military, 15% for motor vehicle or other accident, 
19% for death of a loved one, 19% for childhood physical abuse, 9% for childhood sexual abuse, 
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etc.).  Trauma exposure has been demonstrated to increase risk for future trauma exposure 
(Hanson et al., 1997) and cumulative trauma load is associated with significant medical and 
mental health problems (Fleming et al., 1999).  Thus, investigation into populations that are more 
likely to be exposed to multiple traumas is crucial to the prevention and intervention of these 
negative outcomes.  
  
Trauma Exposure and Risk for Mental Health Disorders in Civilians 
Although trauma exposure is related to a variety of mental health disorders, PTSD is the 
“signature” disorder related to trauma exposure and, thus, will remain the primary focus of this 
study.  PTSD is diagnostically unique from most other psychiatric disorders, such that exposure 
to an environmental event, the traumatic event, is a diagnostic criterion. According to the fourth 
edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV; American 
Psychiatric Association, 2000), exposure to a traumatic stressor is necessary for a PTSD 
diagnosis, wherein an individual must endorse 1) significant threat to life and/or physical integrity 
and 2) feelings of helplessness, fear, or horror.  The newest edition of the DSM (DSM-V; 
American Psychological Association, 2013) eliminated the peritraumatic emotional response 
aspect of criterion A traumatic events within the PTSD diagnosis, such that threat to life and/or 
physical integrity alone is sufficient for PTSD diagnosis eligibility.  Therefore, risk for PTSD can 
be compartmentalized into 1) risk of exposure to a qualifying event and 2) risk of developing 
subsequent PTSD.  Additional changes have been made in the DSM-V concerning PTSD 
symptom clusters.  In the DSM-IV-TR, PTSD symptoms are grouped into three clusters: (1) re-
experiencing of the event (e.g., recurrent and intrusive thoughts, distressing dreams), (2) 
avoidance and emotional numbing (e.g., avoidance of reminders of the traumatic event, restricted 
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range of affect), and (3) hyperarousal (e.g., sleep difficulties, exaggerated startle response).  The 
DSM-V, however, now has four symptom clusters, as the avoidance/numbing cluster was further 
divided into two distinct clusters: avoidance and persistent negative alterations in cognitions and 
mood.  The final cluster, renamed alterations in arousal and reactivity, includes most of the DSM-
IV arousal symptoms, with the addition of irritable, aggressive, reckless and self-destructive 
behavior (American Psychological Association, 2013).  As seen within the symptom clusters, 
sleep disturbances are among the most common symptoms of PTSD (Neylan et al., 1998; Pillar, 
Malhotra, & Lavie, 2000).  An epidemiological study indicated that as many as 91% of PTSD 
patients experience difficulty falling or staying asleep, with upwards of 71% PTSD patients 
endorsing nightmares (Maher, Rego, & Asnis, 2006).   
Notably, differential responses to trauma in the face of these criteria are vast, and 
individuals endorsing these experiences may or may not go on to meet full diagnostic criteria.  
The complex nature of trauma exposure and subsequent developmental outcomes is further 
exemplified by the stark contrast between the alarmingly high prevalence rates of traumatic 
exposure and the substantially lower prevalence rates of PTSD.  Although diagnostic criteria, 
sampling, and assessment strategies have varied within the literature, lifetime prevalence 
estimates across studies using assorted versions of the DSM have been similar.  Nationally 
representative surveys have shown that approximately 3.5% to 9% of individuals will meet 
lifetime criteria for PTSD (Breslau et al., 1998; Kessler, Chiu, Demier, Merikangas, & Walters, 
2005; Kessler et al., 1995), with the highest conditional risk accounted for by those who have 
experienced interpersonal traumatic events (e.g., physical or sexual assaultive violence; Breslau et 
al., 1998; Kessler et al., 1995; Kilpatrick & Resnick, 1993).   
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Exposure to traumatic events has been linked to increased risk for the development of 
internalizing psychiatric disorders beyond PTSD, such as generalized anxiety disorder, panic 
disorder, and major depressive disorder (MDD) (Amstadter et al., 2013; Pietrzak et al., 2011), as 
well as externalizing disorders, including alcohol and substance use disorders (Kilpatrick et al., 
2003).  However, the relationship between trauma exposure and certain externalizing disorders 
has not been invariably demonstrated within the literature (Breslau, Davis, & Schultz, 2003).  
Additionally, the comorbidity between PTSD and these conditions is quite high, with the majority 
of individuals with lifetime PTSD being diagnosed with at least one other lifetime disorder 
(Kessler et al., 1995).  In a nationally representative sample of U.S. adults, PTSD was associated 
with nearly all axis I disorders, including MDD, dysthymic disorder, bipolar I and II disorders, 
GAD, panic disorder, agoraphobia without panic disorder, social and specific phobias, alcohol 
and drug abuse/dependence, and nicotine dependence (Pietrzak et al., 2011).  Furthermore, in a 
national sample of adolescents ages 12-17, nearly three fourths of all adolescents diagnosed with 
PTSD had at least one comorbid diagnosis of either major depressive episode (MDE) or 
substance abuse or dependence (Kilpatrick et al., 2003). 
  
Trauma Exposure and Risk for Mental Health Disorders in Non-Civilians 
Active duty members and veterans embody a crucial demographic when examining pre- 
and post-trauma PTSD risk factors, largely due to this group’s frequent exposure to trauma.  
Consideration of OEF/OIF/OND veterans is particularly relevant, as increasing numbers of 
individuals return from the current conflicts endorsing high rates of combat-related traumatic 
events (Hoge et al., 2006; Hoge et al., 2004).  Notably, prevalence estimates for PTSD are much 
higher among combat veterans than within civilian populations.  Findings from the National 
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Vietnam Veterans’ Readjustment Study (NVVRS; Kulka, 1988) suggest that an estimated 15.2% 
of male and 8.5% female Vietnam veterans met diagnostic criteria for PTSD, but that these rates 
were significantly higher among men (35.8%) and women (17.5%) with high levels of war-zone 
exposure (Schlenger et al., 1992).  Similarly, in a recent meta-analysis, Fulton et al. (2015) found 
that PTSD prevalence among OEF/OIF veterans was estimated at 23%.  As seen in civilian 
populations, military population studies demonstrate a high rate of comorbidity of PTSD and 
internalizing (Hoge et al., 2004) and externalizing (Seal et al., 2011) mental health disorders.  For 
example, combat exposure has been consistently linked to other conditions such as alcohol use 
(Erbes, Westermeyer, Engdahl, & Johnsen, 2007; Hoge et al., 2006; Hoge et al., 2004; Jacobson 
et al., 2008; Smith et al., 2008; Wright, Huffman, Adler, & Castro, 2002), depression (Boscarino, 
1995; Hoge et al., 2004; Scherrer et al., 2008), and anxiety (Boscarino, 1995; Foy, Sipprelle, 
Rueger, & Carroll, 1984).  These findings elucidate the need for increased understanding of the 
risk factors that that may predispose veterans to develop negative mental health outcomes 
following trauma, thus allowing for interventions that are catered specifically to veterans based 
on these specific targeted risk factors.  
 
Discrepancy between Trauma Exposure and PTSD Prevalence 
Although exposure to traumatic events is broadly associated with increased risk for 
psychopathology (Amstadter et al., 2013), the majority of those exposed do not go on to develop 
subsequent mental health disorders (Bonanno, 2004).  This notable difference between trauma 
and PTSD prevalence rates raises the compelling question of what risk factors are at play that 
predispose certain individuals to develop psychopathology following a trauma, but not others.  
This distinction is most likely the result of multidimensional and interdependent developmental 
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factors, including psychosocial/environmental (Naeem et al., 2011) and biological risk factors 
(Amstadter, Sheerin, Lind, & Nugent, in press).  Indeed, twin studies suggest an etiological role 
for both biologic and environmental determinants of PTSD, suggesting that approximately 35% 
of the etiologic risk for PTSD is biological (i.e., can be attributed to additive genetic factors), with 
the remaining proportion of the variance accounted for by environmental factors (e.g., Amstadter, 
Aggen, Knudsen, Reichborn-Kjennerud, & Kendler, 2012; True et al., 1993).  
Psychosocial/environmental factors (e.g., pre- and post-trauma characteristics, trauma type and 
severity, early life adversity) and biological factors (e.g., genetic predisposition) are discussed in 
greater detail in the following sections.   
 
Psychosocial/Environmental Correlates of PTSD 
Gender.  Interestingly, although men are more likely to experience trauma, women are 
more than twice as likely as men to develop PTSD.  Although rates may vary across studies, the 
ratio of females to males who develop PTSD is persistently around 2:1 (Breslau et al., 1998; 
Kessler et al., 1995).  Whereas Breslau and colleagues (1998) found that approximately 13% of 
women develop PTSD, compared to 6.2% of males, Kilpatrick et al.’s findings from the National 
Survey of Adolescents demonstrated lower rates, (6.3% of females vs. 3.7% of males; Kilpatrick 
et al., 2003).  Kessler and colleagues (1995) reported nearly 20.4% of women and 8.2% of men 
go on to develop PTSD following exposure to trauma.  These variations are likely a complex 
function of differences in trauma type and rates of revictimization (Johnson & Thompson, 2008; 
Kessler et al., 1995), as well as sampling and measurement differences across studies.  In a meta-
analysis examining risk factors for PTSD, Brewin and colleagues (2000) offer a number of 
potential suggestions for this gender discrepancy.  First, they posit that higher PTSD rates among 
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women could potentially result from an increased willingness to report PTSD symptomatology 
among women than men.  Alternatively, they suggest that higher rates of PTSD in women could 
result from a cumulative effect of increased exposure to prior trauma.  For example, evidence 
exists to suggest that women’s exposure to childhood sexual abuse, as well as sexual 
revictimization, may account for higher rates of PTSD in adulthood (Arata, 2002; Kaltman, 
Krupnick, Stockton, Hooper, & Green, 2005; Kaysen, Rosen, Bowman, & Resick, 2010; Mollica, 
McInnes, Pham, Smith Fawzi, & Murphy, 1998; Shih, Schell, Hambarsoomian, Belzberg, & 
Marshall, 2010; Wolfe & Kimerling, 1997).  Breslau and colleagues also examined these gender 
differences using data from a broad epidemiological study (1997), but found that higher incidence 
of PTSD in women could not be attributed to cumulative traumatic events.  Instead, after 
controlling for trauma exposure, Breslau et al. showed that women who had experienced 
childhood trauma were more likely than men to develop PTSD.  Supporting this notion, the 
Brewin et al.’s 2000 meta-analysis demonstrated a greater effect size for females when studies 
included childhood traumas as opposed to studies that examined adult traumas exclusively.  
 Gender differences in PTSD have been demonstrated less consistently in veteran samples.  
Contrary to many findings within the civilian literature suggesting that women are significantly 
more likely than men to develop PTSD (Breslau et al., 1998; Kessler et al., 1995; Kilpatrick et al., 
2003), a study comparing VA medical records of 1,129 male and female OEF/OIF veterans 
(Haskell et al., 2010) found that female veterans were significantly less likely to screen positive 
for PTSD than their male counterparts (21% vs. 33%, respectively).  This finding could be 
explained by higher rates of combat exposure among men than woman, as amount of combat 
exposure is positively associated with PTSD (Smith et al., 2008).  Conversely, however, another 
study using similar methods (Maguen, Ren, Bosch, Marmar, & Seal, 2010) found that female 
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veterans were significantly more likely to receive a PTSD diagnosis than their male counterparts, 
a finding more consistent with the civilian literature.  Alternatively, evidence from multiple 
studies suggests that, although prevalence of probable PTSD may vary between the sexes by type 
of traumatic event (e.g., sexual harassment vs. combat exposure) occurring during deployment, 
rates of deployment-related PTSD do not differ significantly between men and women (Street, 
Gradus, Giasson, Vogt, & Resick, 2013; Vogt et al., 2011; Vogt, Pless, King, & King, 2005).  
Shared pre- and post-trauma variables could help to explain this lack of gender effects with 
regards to combat-related PTSD.  For example, King et al. (1999) found that men and women 
shared six variables that were associated with risk for PTSD (early trauma history, abusive 
violence and perceived threat during deployment, post-deployment stressful life events, hardiness, 
and functional support).  Although men had an additional three variables that were associated 
with PTSD, including pre-deployment age, adverse war-zone environment, and structural social 
support post-deployment, early history of exposure to trauma was directly linked to post-
deployment stressful life events for both genders, consistent with Bremner et al.’s (1995) 
conclusion that prior life stress predicts later life stress.  To that end, more recent investigations of 
OEF/OIF veterans have also shown that certain deployment variables, such as perceived threat in 
the war zone and combat stress, do not differ according to gender (Street et al., 2013; Vogt et al., 
2011).    
Race. Race is another demographic variable that has been examined throughout the 
literature in association with PTSD.  There is evidence to suggest that minority race status is 
associated with increased risk for exposure to trauma (Breslau et al., 1998), and minority race was 
one of the few demographic variables found to be a predictor of greater likelihood of PTSD, 
albeit with a low effect size, in a meta-analysis of risk factors for PTSD (Brewin et al., 2000).  
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However, some studies have demonstrated that race, although a significant independent predictor 
of PTSD, becomes a non-significant predictor when simultaneously accounting for other 
variables (Breslau et al., 1998; Brewin, Andrews, & Valentine, 2000).  Notable, however, is the 
fact that race was a significantly stronger predictor in military samples than in civilian samples in 
the meta-analysis.  Koenen et al. (2003) found that, compared to male veterans who had never 
been diagnosed with PTSD, those who had PTSD at any time in their life were more likely to be 
of a minority race.  Although some studies have demonstrated that minority status is associated 
with increased risk for PTSD, effect sizes are often small and there is little support in the existing 
literature for race as an independent risk factor for PTSD (Brewin et al., 2000).   
Early environment. In addition to demographic correlates, early environmental factors 
may also confer risk for PTSD.  Low childhood socioeconomic status (SES), child abuse, and 
familial psychiatric history, which could be thought of as an early biologic risk factor, have been 
repeatedly demonstrated to be associated with increased risk for PTSD within civilian samples 
(Brewin et al., 2000; Davidson, Hughes, Blazer, & George, 1991; Koenen, Moffitt, Poulton, 
Martin, & Caspi, 2007; Ozer, Best, Lipsey, & Weiss, 2003; Ozer, Best, Lipsey, & Weiss, 2008).  
Other early environmental predictors of PTSD include frequent changes in residencies, changes in 
parental figures, and separation or divorce of parents before age 10 (Brewin et al., 2000; 
Davidson et al., 1991; Koenen et al., 2007; Ozer, Best, Lipsey, & Weiss, 2003; Ozer et al., 2008).  
Early environmental influences on development of PTSD are also seen within military 
populations.  In a study on familial and individual risk factors for PTSD, Koenen et al. (2002) 
found that maternal antisocial behavior, paternal depression, and less than a high-school 
education at entry into military were significant predictors of PTSD.  Moreover, the effects of 
early family instability have also been shown to negatively affect functioning post trauma 
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exposure in adulthood within military samples (King et al., 1999).  More specifically, a negative 
association between early familial instability and later social support has been demonstrated in 
male veterans, both of which serve as risk factors for PTSD (Jones, 1996; King et al., 1999; Main, 
1996).  The negative effect of early family instability on later social support is an important 
developmental consideration when attempting to conceptualize the processes in which individuals 
formulate secure attachments and build social support networks, which may act as buffering 
agents that protect against the development of PTSD following exposure to trauma (Boscarino, 
1995).  
Trauma type and frequency. Trauma type may also influence the likelihood that an 
individual will develop PTSD.  Of importance, trauma measures within civilian studies can be 
highly variable, with trauma severity assessments differing across multiple types of trauma, as 
well as within trauma types.  This heterogeneity is both necessary and unavoidable, as it provides 
a representative picture of the multiplex nature of trauma exposure and PTSD.  In spite of these 
disparate exposures and responses to trauma, the association between certain trauma types and 
PTSD have been consistent across the literature (Brewin et al., 2000).  For example, several meta-
analytic and epidemiological studies have demonstrated that the predictive effects of trauma type 
on PTSD vary according to gender.  Kessler et al. (1995) found in the National Comorbidity 
Study that males who had experienced combat exposure were at highest risk for PTSD, followed 
by males who had witnessed someone being killed or who had experienced  a serious injury or 
accident.  For females, rape and molestation were most frequently associated with PTSD, 
followed by physical abuse or threat with a weapon (Kessler et al., 1995). Perkonigg and 
colleagues (2000) similarly demonstrated that female victims of rape and sexual abuse were at 
highest conditional risk for PTSD, although the base rate for PTSD among males was too low to 
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allow interpretation.  Another frequently replicated epidemiological finding is the positive 
association between cumulative effects of trauma and PTSD likelihood, such that individuals 
exposed to multiple traumatic events experience an enhanced probability of PTSD (Breslau, 
2009).  Additionally, these cumulative effects have been shown to be predictive of PTSD 
symptomatology, wherein greater exposure is predictive of greater PTSD symptomatology 
(Cloitre et al., 2009; Messman-Moore, Long, & Siegfried, 2000). 
Combat-specific characteristics that have been shown to increase risk for chronic PTSD 
include type of trauma, amount of exposure, injury, involvement in atrocities, and perceived life 
threat (Engdahl, Dikel, Eberly, & Blank, 1997; Green, Grace, Lindy, Gleser, & Leonard, 1990; 
King, King, Foy, & Gudanowski, 1996; Kulka et al., 1990; Wolfe, Erickson, Sharkansky, King, 
& King, 1999).  Type of combat exposure plays an influential role in the progression of 
subsequent psychopathology in military samples, such that veterans with direct combat exposure 
are three times more likely to receive a PTSD diagnosis post-deployment when compared to those 
without direct combat exposure (Smith et al., 2008).  Furthermore, a positive relationship between 
amount of combat exposure and the development of PTSD has been demonstrated in the extant 
literature (i.e., more combat exposure is associated with greater risk of PTSD; Dohrenwend et al., 
2006; McNally, 2006).   
Social support. There is strong evidence to suggest that social support is a highly 
influential predictor of PTSD onset and maintenance (Kaniasty, 2005).  Social support, which is 
typically categorized as received support (actual receipt of help), social embeddedness (quality 
and type of relationships with others), or perceived support (the belief that help would be 
available if needed) (Kaniasty, 2005), is based on two dominant theoretical models.  The first 
model, known as the stress buffer (interactive) model posits social support serves as a protective 
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mechanism from potentially adverse effects of stressful events.  The second model, known the 
main effect (additive) model, refers to social support that is directly beneficial to the recipient 
(Cohen & Wills, 1985; Wills, Shinar, Cohen, Underwood, & Gottlieb, 2000). Although 
differences in definition and measurement of social support result in some empirical limitations, 
reviews of the literature generally point to the beneficial effects that social support has on 
psychological well-being (Holahan & Moos, 1981) and physical health (Uchino, 2004).  Notably, 
meta-analytic reviews of PTSD risk and protective factors have found that perceived social 
support is the strongest predictor of PTSD (Brewin et al., 2000; Ozer et al. 2003).   
Several studies have examined multiple factors affecting the relationship between social 
support and PTSD within civilian populations.  The association between perceived social support 
and PTSD has been frequently demonstrated in the literature (Eriksson, Kemp, Gorsuch, Hoke, & 
Foy, 2001; Fleming, Baum, Gisriel, & Gatchel, 1982; Holeva, Tarrier, & Wells, 2002; Ozer & 
Weinstein, 2004; Platt, Keyes, & Koenen, 2014).  However, Platt et al. (2014) found that low 
social role diversity (e.g., employee, parent, friend, church member, etc.) was significantly 
associated with having a current PTSD diagnosis, irrespective of high or low perceived social 
support.  Additionally, Andrew and colleagues (2003) demonstrated both a mediating effect of 
event-specific negative social support on the association between gender and PTSD, as well as a 
moderating effect of gender on the relationship between event-specific social support and PTSD.  
A longitudinal study investigating the relationship between social support and PTSD at 4 weeks 
and 16 weeks post-trauma showed that, while social support was not associated with PTSD 
symptom severity at 4 weeks, greater perceived social support and positive social interaction, as 
well as lower negative social interaction, were each associated with reductions in PTSD symptom 
severity from 4 weeks to 16 weeks among individuals with elevated PTSD symptom severity at 4 
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weeks (Robinaugh et al., 2011). Interestingly, the relationship between social support and 
negative social interaction was no longer significant when analyzed in conjunction with negative 
post-trauma cognitions, suggesting that perceived social support and negative interactions were 
associated with maintenance of PTSD symptom severity due to the association with negative 
posttrauma cognitions.   
 Examining the buffering effects of social support against PTSD among veterans has 
enabled a unique look into the influences of social support pre-trauma (pre-deployment), 
peritrauma (during deployment) and post-trauma (post-deployment).  As previously discussed, a 
negative relationship between early family instability and later social support has been 
demonstrated among male veterans (Jones, 1996; King et al., 1999; Main, 1996), implicating 
crucial processes in which the formulation of social attachment and social support networks 
works to buffer against the effects of trauma exposure (Boscarino, 1995).  Interestingly, while 
temporal restrictions have resulted in very few studies being able to investigate the effects of pre-
deployment social support, the one study, to our knowledge, to have investigated this relationship 
suggests that pre-deployment social support does not have a significant influence on the 
development of PTSD post-deployment (Han et al., 2014).  However, several studies have 
demonstrated significant influences of deployment unit support and post-deployment support on 
subsequent PTSD (Koenen et al., 2003; Pietrzak et al., 2010; Pietrzak, Johnson, Goldstein, 
Malley, & Southwick, 2009; Tsai, Harpaz-Rotem, Pietrzak, & Southwick, 2012). Although the 
majority of studies have examined this relationship cross-sectionally, Koenen et al. (2003) 
followed an all male sample of Vietnam veterans longitudinally over a 14-year span and found 
that, when compared to individuals without a PTSD diagnosis, those with PTSD at any time were 
more likely to report less perceived social support upon return from deployment.  Additionally, 
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veterans with PTSD at any of the assessed time points were more likely to report perceived 
negative community attitudes upon returning from deployment than any other group (Koenen et 
al., 2003).  These findings are consistent with much of the extant military literature, which 
suggests that PTSD is linked to low post-deployment social support, negative homecoming 
experiences, poor social functioning, lower partner satisfaction, and poor coping and 
posttraumatic life events (Boscarino, 1995; Engdahl et al., 1997; Green et al., 1990; Han et al., 
2014; King, King, Fairbank, Keane, & Adams, 1998; Laffaye, Cavella, Drescher, & Rosen, 2008; 
Pietrzak et al., 2010; Pietrzak et al., 2009; Solomon, Mikulincer, & Avitzur, 1988; Tsai et al., 
2012).  Of importance, although the vast majority of research provides strong evidence to suggest 
that social support plays a buffering role to the deleterious effects of PTSD, Brancu and 
colleagues (2014) found that the protective effects of social support against psychological distress 
among veterans with PTSD were minimal, such that levels of psychological distress were 
alleviated by only approximately 5% by high levels of social support for individuals with PTSD, 
as compared to the nearly 25% reduction in distress for the TE and NTC groups.  These findings, 
derived from a sample of 1,825 Veterans as part of a multi-site VA study, could be explained by 
an increased difficulty with interpersonal relationships that accompanies many of the core 
symptoms of PTSD, such as avoidance, hyperarousal, and emotional numbing (Friedman, 2006).  
It is markedly important to consider that, although risk factors for PTSD vary across 
studies, a small number of variables have been consistently demonstrated to significantly 
influence PTSD risk, including psychiatric history, early childhood experiences (i.e., abuse, 
trauma), and family history (Brewin et al., 2000).  Some risk factors had larger effect sizes among 
veteran populations compared to other groups.  For instance, effect sizes for severity of trauma 
and social support following trauma were larger in military than in civilian samples (Brewin et 
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al., 2000).  Additionally, the Brewin meta-analysis found that other important risk factors for 
veterans included younger age at the trauma, lower education, minority status, and family 
adversity.  Furthermore, although many of these aforementioned risk factors account for 
relatively little of the variance for PTSD when examined independently, aggregating them could 
result in a more complete etiologic picture of PTSD.  For example, the cumulative effects of pre-
trauma factors might outweigh the seemingly larger effect of trauma severity (Brewin et al., 
2000).  It is crucial, however, to account for the likely intercorrelations among many of these pre-
trauma variables (e.g., child abuse and family history).  In sum, psychosocial/environmental 
factors that account for approximately two thirds of variance in PTSD, with the remaining 
variance being attributed to genetic factors (Amstadter et al., 2012), have begun to be identified. 
  
Biological Underpinnings of PTSD 
Although psychosocial and environmental factors, such as early life events and perceived 
social support, play an influential role in the development of PTSD, investigation into the 
etiological influences of variables beyond the environment is essential.  Biological and genetic 
mechanisms underlying risk for PTSD are critical and account for approximately one third of the 
variance in PTSD (Amstadter et al., in press; Mehta & Binder, 2012; Skelton, Ressler, Norrholm, 
Jovanovic, & Bradley-Davino, 2012; Van der Kolk, 1997; Yehuda, 2001).  Because a minimum 
of 4 weeks following the exposure to trauma is required for a PTSD diagnosis (American 
Psychological Association, 2013), PTSD is often understood as a maladaptive and continuous 
stress response, wherein an individual’s biological stress response fails to acclimate appropriately 
to the stressor and instead experiences progressive dysregulation (McFarlane, 2000).   
Converging evidence from multidisciplinary research designs has demonstrated a genetic, 
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and thus biological, role in the development of PTSD.  This support is drawn from family, twin, 
and molecular genetic studies (Koenen, 2007).  Family studies have supported the notion that, if 
PTSD etiology does have genetic influences, then relatives of individuals with PTSD should have 
a higher prevalence of PTSD than do nonrelatives, indicating increased risk for PTSD in relatives 
(Amstadter, Nugent, & Koenen, 2009).  As previously mentioned, twin studies provide 
heritability estimates for PTSD, offering insight into the relative contribution of genetic and 
environmental influences on the variance in PTSD risk (Nugent, Amstadter, & Koenen, 2008).  In 
doing so, twin studies also highlight the importance of gene-environment correlations, wherein 
selection of environment (and thus, potential for trauma exposure) are partially influenced by 
genetic factors (Kendler & Eaves, 1986).  For example, twin studies have demonstrated that 
genetic factors influence the likelihood of experiencing a traumatic event, including combat 
exposure (Lyons et al., 1993) and assaultive violence (Stein, Jang, Taylor, Vernon, & Livesley, 
2002).  Personality, which is moderately heritable, plays a likely role in an individual’s selection 
into potentially traumatic environments (Nugent et al., 2008).  Although twin studies provide 
support for gene-environment correlations, demonstrate a genetic role in the etiology of PTSD, 
and offer genetic insight into comorbidity (Nugent et al., 2008), they are unable to identify 
specific genes associated with the disorder.   
Studies of molecular genetics help to identify specific genes related to PTSD risk.  
Compared to other psychiatric disorders, molecular studies for PTSD are somewhat limited in 
number, as this research is still in its infancy.  Most of the previous research has focused on 
examining genes in the biological systems associated with the fear response, including the HPA-
axis, as well as the dopaminergic and serotonergic systems involving neural pathways underlying 
emotion and memory consolidation (Logue et al., 2015).  However, the field of psychiatric 
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genetics has made a shift towards genome-wide association studies (GWAS), wherein large 
sample sizes allow for the detection of unsuspected genes and molecular pathways, as opposed to 
limiting testing to a small number of hypothesized genes as in candidate gene studies.  
 Indeed, family, twin, and molecular studies of PTSD have evidenced a genetic role in the 
etiology of the condition. Additionally, a wealth of literature (e.g., Pervanidou, 2008; Southwick, 
Rasmusson, Barron, & Arnsten, 2005; Van der Kolk, 1997; Yehuda, 1999; Yehuda, 2001) has 
investigated the biological underpinnings of the disorder, including physiological, neurological, 
and neuroendocrine processes.  However, when reviewing this literature, it is important to 
differentiate between biological correlates and risk factors of PTSD.  This distinction is based 
largely on broad differences in study designs.  For example, an abundance of literature exists 
documenting biological correlates of PTSD, which are more clearly identified as markers of the 
disorder or disease process (aka “PTSD signs”; Amstadter et al., in press).  Literature 
investigating risk factors, or predictors, of PTSD is less prevalent, however, as temporality is 
paramount in identifying whether certain risk/vulnerability factors (aka “biomarkers”) precede the 
development of PTSD (Amstadter et al., in press).  Because the nature of trauma exposure is 
characteristically unpredictable, identifying risk factors of PTSD proves a methodological 
challenge.  Investigation into biological PTSD correlates, on the other hand, is more feasible, 
using traditional case-control designs to assess whether certain biological markers appear more 
prevalently in individuals with PTSD compared to trauma-exposed individuals who do not 
develop PTSD (Amstadter et al., in press). 
 
HPA-Axis Functioning in PTSD 
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Findings suggesting that pre-existing PTSD symptomology may be routinely triggered by 
everyday stressful life events (e.g., a loud car alarm triggers physiological arousal) implies that 
gradual modification of an individual’s stress responsivity may play an important role in the 
psychobiological dysregulation that is paramount in PTSD (McFarlane, Atchison, Rafalowicz, & 
Papay, 1994; van der Kolk, Greenberg, Boyd, & Krystal, 1985).  Therefore, an individual’s 
immediate response following trauma may not accurately determine the course that is to follow.  
Naturally, vulnerability and protective factors are both pertinent in this critical period following 
exposure to trauma.  An individual’s capability to attune to the acute stressor and recover 
physiological and biological homeostasis is equally important (McFarlane, 2000).  Thus, because 
the vast majority of trauma-exposed individuals do not go on to develop PTSD (Breslau et al., 
1998), the question remains as to what is happening under the skin that makes certain individuals 
more vulnerable than others to developing psychopathology.  Examination of biological 
correlates of PTSD has led to a large amount of research pointing neuroendocrine system activity 
(e.g., Golier, Schmeidler, Legge, & Yehuda, 2007; Meewisse, Reitsma, De Vries, Gersons, & 
Olff, 2007; Miller, Chen, & Zhou, 2007; Morris, Compas, & Garber, 2012; Yehuda, 2002). 
The sympathetic nervous system (SNS) and hypothalamic-pituitary-adrenal (HPA) axis 
are essential elements in the body’s neuroendocrine response to stress, be it emotional or 
physical.  Exposure to an acute stressor triggers the SNS to enact a “flight-or-flight” response 
(Cannon, 1929), which elicits the HPA axis to initiate a process to return the body to homeostasis. 
This process is conducted by glucocorticoids (e.g., cortisol), the main output of the HPA stress 
response (Sapolsky, Romero, & Munck, 2000).  Glucocorticoids are hormones released by the 
adrenal cortex that affect bodily responses to stressful stimuli to better enable an individual to 
deal with stress.  In response to a stressor, the hypothalamus activates, resulting in the secretion of 
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corticotropin-releasing hormone (CRH) and arginine vasopressin.  These hormones, in turn, 
trigger the pituitary release of adrenocorticotropin-releasing hormone (ACTH), which signals the 
adrenal glands to release glucocorticoids into the bloodstream (Handwerger, 2009).  Bodily 
responses affected by this process include increased cardiovascular tone, concentration of energy 
to muscles, immune system stimulation, reproductive physiology and appetite inhibition, and 
increased cerebral perfusion rates and cognition (Sapolsky et al., 2000).  
The HPA axis responds to glucocorticoid release by means of a negative feedback loop, 
whereby the hippocampus signals the hypothalamus to terminate glucocorticoid release, restoring 
basal HPA axis functioning and, thus, homeostasis (Handwerger, 2009).  It is pertinent that 
homeostasis be reinstated in order to engender adaptive changes, such as stress recovery and 
resilience (De Kloet, Joëls, & Holsboer, 2005).  Without this termination of glucocorticoid 
release, the duration of time that bodily tissues are exposed to glucocorticoids can be damaging, 
underscoring the importance of the HPA axis negative feedback loop system (Habib, Gold, & 
Chrousos, 2001).  Maladaptive functioning of this system may occur by means of unnecessary 
activation, lack of activation, or lack of termination (Handwerger, 2009).  Chronic or severe stress 
(e.g., trauma) can lead to the perpetuation or failure of the stress system activation, prompting the 
development of an allostatic load wherein physiologic systems are more vulnerable to stress, 
resulting in the development of disease (e.g., psychiatric, circulatory, metabolic, gastrointestinal, 
and immunologic; De Kloet et al., 2005; Flier, Underhill, & McEwen, 1998; Mayer, 2000).   
The final product of the HPA axis, cortisol, is typically used to assess HPA functioning.  
Cortisol follows a diurnal rhythm, peaking in early morning and decreasing throughout the day 
(Desir et al., 1980).  This fluctuation calls relevance to assessment times and methods, especially 
if HPA functioning is being assessed under basal conditions.  Examination of baseline cortisol 
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levels usually occurs at a standardized point within the diurnal pattern, such as early morning, or 
late afternoon, when cortisol is highest in intra-individual stability (Pruessner et al., 1997).  Some 
studies examining the modulation of cortisol and ACTH by metabolic inputs relating to blood 
glucose levels suggest that around 5PM may be the time in which cortisol is most stable (Lovallo, 
2006; Van Cauter, Shapiro, Tillil, & Polonsky, 1992).  The spike in cortisol levels following 
morning awakening is referred to as the cortisol awakening response (CAR; Pruessner et al., 
1997) and implicates the major role the HPA-axis plays in sleep and awakening.  Thus, 
dysregulation of this system has been demonstrated to have a physiological impact on sleep 
(Clow, Hucklebridge, Stalder, Evans, & Thorn, 2010).  In normal HPA circadian rhythm 
functioning, the nadir for cortisol occurs around midnight (Buckley & Schatzberg, 2005).  
Cortisol levels begin to increase approximately 2-3 hours following onset of sleep, and continue 
to rise throughout the duration of sleep until they peak around 9AM (Turek & Zee, 1999).  
Following, cortisol levels decline steadily until they again reach their nadir around midnight the 
following night (Buckley & Schatzberg, 2005).  Throughout this circadian process, CRH is 
concurrently being released in a circadian, pulsatile manner, which in turn controls the subsequent 
release of ACTH into the bloodstream (Hauger & Dautzenberg, 2000).     
Because the HPA-axis works to modulate the secretion of cortisol and ACTH on a diurnal 
rhythm, frequent abrupt shifts in the sleep period can induce consequential disruptions in 
neuroendocrine regulation (Buxton, Copinschi, Van Onderbergen, Karrison, & Van Cauter, 
2000).  Additionally, sleep deprivation and/or reduced quality of sleep have been linked to 
adjustments of HPA axis activation (Balbo, Leproult, & Van Cauter, 2010).  Thus, the 
bidirectional relationship between sleep and HPA axis functioning serves to either maintain 
healthy sleep and neuroendocrine regulation or dysregulation.  This relationship has been further 
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evidenced in both animal and human studies, which have confirmed the existence of functional 
relationships between fear and sleep systems in the brain (Woodward, 2004).  Although 
substantial evidence exists to suggest that HPA axis functioning and sleep disturbances, 
separately, are associated with PTSD, these interdependent relationships are not well understood.  
In addition to sleep, social support has also been shown to affect HPA-axis activity.  
Previous studies have demonstrated low social support to be associated with significant increases 
in HPA reactivity, including cortisol secretion, following lab-induced stress (Kirschbaum, Klauer, 
Filipp, & Hellhammer, 1995; Ozbay, Fitterling, Charney, & Southwick, 2008; Steptoe, Owen, 
Kunz-Ebrecht, & Brydon, 2004).  Similarly, another study using a laboratory-induced stress 
paradigm demonstrated that individuals who received a combination of oxytocin and social 
support had the least amount of anxiety and lowest cortisol responses to stress (Heinrichs, 
Baumgartner, Kirschbaum, & Ehlert, 2003).  This is in line with evidence suggesting that 
oxytocin, a neuropeptide recognized for promoting social behavior, may serve as a physiological 
link between positive social interactions and suppression of the HPA-axis (DeVries, Glasper, & 
Detillion, 2003).  Furthermore, one study found that, even after controlling for stress, basal 
cortisol was inversely related to social support among individuals with high social support, 
indicating a positive effect of social support on the HPA axis (Rosal, King, Ma, & Reed, 2004).   
Although the HPA axis is designed to handle transitory stress, effects of extreme or 
prolonged trauma exposure, resulting in PTSD, have been shown to be associated with long-term 
HPA axis dysregulation (Olszewski & Varrasse, 2005; Yehuda, 1997).  Evidence examining the 
relationship between PTSD and subsequent HPA activity has been inconsistent in the extant 
literature.  Although the majority of studies suggest that individuals with PTSD resulting from an 
acute traumatic incident typically exhibit lower basal cortisol when compared to trauma exposed 
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and non-trauma exposed controls, this has not been consistently demonstrated.  Lower cortisol 
levels might implicate long-term effects resulting from a constant increase in allostatic load 
(Handwerger, 2009).  While, intuitively, greater increases in cortisol are commonly found 
following a laboratory stressor among subjects with PTSD compared to subjects without PTSD, 
the question remains as to why the majority of studies examining baseline cortisol find lower 
basal levels among individuals with PTSD.  A growing line of literature is examining genetic 
variants that affect the HPA axis function (e.g., Mehta & Binder, 2012), but the question further 
remains as to why, although the minority, other studies demonstrate opposite findings.  
A disruption in the HPA axis’s homeostatic negative feedback loop could likely account 
for the acquisition of the physiologic system to a new norm, in which the HPA axis operates as it 
would in response to stress in healthy individuals at baseline conditions in PTSD positive 
individuals (Handwerger, 2009; Olszewski & Varrasse, 2005; Yehuda, 1997).  More specifically, 
some studies suggest that elevated cortisol resulting from trauma leads to subsequent sensitization 
of the nervous system’s CRH pathways (Heim & Nemeroff, 1999; Yehuda, 1997).  This increase 
in SNS functioning leads to an escalation of HPA functioning, resulting in elevated cortisol 
secretion.  Higher levels of cortisol secretion consequently exaggerate the negative feedback loop, 
resulting in lower baseline cortisol levels (Handwerger, 2009; Tucker et al., 2004).  The present 
study aimed to review the current literature on the relationship between PTSD and two HPA axis 
markers (cortisol and ACTH) at a resting state, and to further examine these markers within a 
sample of OIF/OEF/OND veterans.   
 
Studies Finding Lower Cortisol 
Studies examining basal cortisol levels in relation to PTSD are often contradictory.  
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However, reports of lower basal cortisol in PTSD-positive individuals are more prevalent within 
the literature.  In a meta-analysis examining basal and reactive cortisol in control, trauma 
exposed, and PTSD positive adults, some studies reported lower cortisol levels in PTSD patients 
compared to nonclinical samples (De Kloet et al., 2007; Neylan et al., 2005; Rohleder, 
Joksimovic, Wolf, & Kirschbaum, 2004; Wessa, Rohleder, Kirschbaum, & Flor, 2006; Yehuda, 
Golier, & Kaufman, 2005), although cortisol levels did not significantly differ meta-analytically 
for trauma exposed (TE) vs. PTSD or control vs. PTSD (Klaassens, Giltay, Cuijpers, van Veen, & 
Zitman, 2012).  Additional studies found enhanced cortisol suppression in patients with PTSD 
(Yehuda, Halligan, Golier, Grossman, & Bierer, 2004; Yehuda, Halligan, Grossman, A Golier, & 
Wong, 2002; Yehuda, Southwick, Krystal, et al., 1993) but also in trauma-exposed veterans 
without PTSD (De Kloet et al., 2007), signifying lower levels of cortisol in TE and PTSD 
individuals assessed at baseline.  Notably, basal cortisol levels were lower in military veterans 
with PTSD in the first hour after awakening compared to non-trauma-exposed civilian controls.  
However, compared to the TE group, no differences in cortisol measurements were reported (De 
Kloet et al., 2007; Klaassens et al., 2012).  Horn et al. (2014) measured morning plasma cortisol 
levels in a civilian sample consisting of PTSD, TE, and non-trauma control (NTC) groups.  After 
controlling for Caucasian ethnicity, education, lifetime alcohol use disorder, and current smoking 
status, the PTSD and TE groups exhibited significantly lower cortisol levels than the NTC group.  
Cortisol levels between the PTSD and TE groups did not differ.  Interestingly, only age and 
severity of emotional numbing symptoms were significantly associated with cortisol levels in the 
PTSD group.   
Several studies highlight the importance of considering psychiatric comorbidity when 
examining HPA axis markers.  A meta-analysis investigating HPA functioning in PTSD and 
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PTSD comorbid with MDD found that daily cortisol output was significantly lower for PTSD and 
comorbid PTSD and MDD groups, compared to the NTCs (Morris et al., 2012).  TE and NTC 
groups did not differ significantly.  Morris and colleagues suggest that the inconsistent literature 
on HPA function in PTSD is due, in part, a failure to consider the commonly occurring 
psychiatric comorbidities, namely MDD, that often accompany PTSD diagnoses.  The authors 
also argue that including TE individuals in control groups further contributes to inconsistent 
findings within the literature, such that TE and NTC groups are combined into one comparison 
group.  Newport et al. (2004) also considered comorbidity in their study examining women with 
childhood abuse diagnosed with PTSD, MDD, or comorbid PTSD and MDD and found that, 
compared to healthy controls, individuals with early childhood abuse and PTSD had significantly 
lower baseline plasma cortisol levels and revealed significantly more suppression of morning 
cortisol.   
In their systematic review and meta-analysis, Meewisse and colleagues (2007) found no 
significant baseline cortisol differences between PTSD and control groups when comparing 
systematic mean differences, which allowed them to pool across studies that used different types 
of measurement (i.e., urine, saliva, plasma, or serum).  However, subgroup analyses demonstrated 
that studies assessing cortisol via plasma or serum showed significantly lower levels in people 
with PTSD when compared to NTC.  Additionally, lower basal cortisol levels were seen among 
PTSD groups in studies that included females, assessed physical and/or sexual abuse, and 
sampled in the afternoon, where cortisol levels are likely most stable.  Significant differences in 
measurement methodology highlight the need to investigate assessment variability in studies 
examining neuroendocrine differences in HPA functioning.  Furthermore, assessment modality 
should be taken into consideration when interpreting extant findings, as significant group 
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differences could be influenced by how the samples were collected.  The relationship between 
lower cortisol demonstrated only in afternoon samples and not demonstrated in any other time 
points, could elucidate the need to choose time of measurement carefully.   
 
Studies Finding Higher Cortisol 
 Although the majority of studies within the extant literature have demonstrated overall 
lower baseline cortisol levels among PTSD-positive individuals, and frequently TE individuals as 
well, a number of studies have reported higher basal cortisol levels in patients with PTSD 
(Inslicht et al., 2006; Klaassens et al., 2012; Lindley, Carlson, & Benoit, 2004).  Baker et al. 
(2005) compared CSF, plasma, and urinary cortisol measurements in individuals with combat-
related PTSD to healthy controls.  Although no group differences were detected in the plasma or 
urinary free cortisol, mean CSF cortisol concentrations were significantly higher in the PTSD-
positive individuals than in the healthy controls.  In attempting to explain this incongruence of 
findings between assessment modalities, the authors posit that CSF cortisol more accurately 
illustrates brain glucocorticoid exposure.  Of additional importance is that CSF, CRH, and CSF 
cortisol were positively and significantly correlated in this sample. 
 In a larger study examining HPA response to administration of synthetic corticotrophin-
releasing factor (CRF) stimulation in a sample of military veterans (Golier et al., 2012), baseline 
levels of cortisol were significantly higher in veterans in the PTSD group compared to the TE and 
NTC groups.  Similarly, baseline analyses from a study examining subjective, autonomic, 
adrenergic, and HPA axis responses in PTSD and TE Vietnam veterans and healthy non-veteran 
controls (Liberzon, Abelson, Flagel, Raz, & Young, 1999) indicated that PTSD patients, as 
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compared to TE and NTC groups, had higher subjective distress, skin conductance, NE, and 
plasma cortisol.  TE and NTC groups did not differ significantly on any baseline measures.  
Other studies considering psychiatric comorbidity when examining the HPA axis have 
demonstrated higher levels of baseline cortisol within comorbid groups.  Findings from a 
subsample of a large epidemiological study showed significant elevations in cortisol among 
individuals with comorbid PTSD and MDD, but not in PTSD or MDD only groups (Young & 
Breslau, 2004). Young and Breslau compared salivary cortisol between PTSD, TE, and 
PTSD+MDD groups and found that evening cortisol levels were higher in the PTSD group 
compared to TE individuals, but that the only statistically significant difference in cortisol was 
demonstrated within the comorbid group.  
 
Studies Finding No Differences in Cortisol 
 Some studies failed to find any significant differences in basal cortisol between study 
groups.  Results from several meta-analyses indicate no significant differences in basal cortisol 
levels between individuals with PTSD and controls (Klaassens et al., 2012; Meewisse et al., 2007; 
Miller et al., 2007).  However, as previously mentioned, subgroup analyses within these samples 
typically did reveal significant differences, depending on considered variables.  In addition to 
these meta-analyses, Savic et al. (2012) compared 400 individuals by group (current PTSD, 
lifetime PTSD, TE, NTC) and found no significant differences in basal cortisol, measured in 
blood and taken hourly from 10PM to 9AM, between study groups.  In another study, Hockings 
et al. (1993) compared 13 Vietnam Veterans with PTSD to 7 healthy controls and found no 
significant differences in baseline plasma cortisol levels.  Another study by Lindley and 
colleagues (2004) additionally found no significant differences in baseline salivary cortisol levels, 
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assessed at multiple time points over two consecutive days, in a sample of 17 individuals with 
PTSD resulting from various types of trauma and 17 matched controls. 
 
Studies Finding Higher ACTH  
 Studies examining baseline ACTH have also demonstrated mixed findings, but are overall 
less variable than those examining basal cortisol levels.  In behavioral medicine, ACTH is 
assayed less frequently than it’s neuroendocrine counterpart, cortisol, largely because it is blood-
based biomarker.  Unlike cortisol, which can be assessed via several biological specimens (e.g., 
saliva, blood, hair), ACTH is limited to serum-based assessment, resulting in fewer studies 
investigating its association with PTSD.  However, whereas the literature on the association 
between PTSD and cortisol is highly variable, standardization of ACTH assessment results in a 
more consistent literature.  Overall in the literature, basal ACTH has been found to be 
significantly higher in individuals with PTSD, or to not differ significantly altogether.  In a study 
by Kloet et al. (2012) analyzing HPA axis, immunological, and SNS system responses to 
cognitive stress in combat exposed PTSD veterans and combat TE controls, basal ACTH levels 
were significantly higher in PTSD patients compared to controls.  Another study examining 
baseline HPA functioning and biological correlates of PTSD in Gulf War veterans, Golier and 
colleagues (2007) found significantly higher basal levels of ACTH in the PTSD compared to the 
TE group.  Interestingly, ACTH levels were also significantly higher in the NTC group compared 
to the TE group.  Significant differences between PTSD and NTC groups were not discussed.    
 
Studies Finding No Differences in ACTH 
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The majority of studies investigating ACTH levels in relation to PTSD have failed to find 
significant differences in baseline ACTH between groups.  In Savic et al.’s (2012) study 
comparing 400 individuals with current PTSD, lifetime PTSD, TE, or NTC, no significant 
differences in basal ACTH were found between study groups.  Additionally, Baker and 
colleagues (2005) demonstrated no significant group differences in basal plasma ACTH between 
males with combat related PTSD and NTC.  In another military sample investigating HPA 
functioning among several generations of veterans, Golier and colleagues (2012) found no 
significant differences in baseline ACTH between PTSD, TE, and NTC groups.  Similarly, a 
study by Liberzon et al. (1999) examining HPA axis, subjective, autonomic, and adrenergic 
responses in Vietnam veterans showed no significant differences in baseline ACTH levels 
between PTSD, TE, and NTC groups. 
 
Possible Explanations of Contradictory Findings 
The disparate findings implicating lower levels of cortisol, yet higher levels of ACTH in 
the majority of individuals with PTSD is likely a function of the HPA Axis’s negative feedback 
loop.  Stress-induced hypothalamic activation triggers CRH and arginine vasopressin to signal 
pituitary release of ACTH.  This increase in ACTH then leads the hippocampus to signal the 
hypothalamus to halt glucocorticoid (e.g., cortisol) production (Handwerger, 2009).  Thus, 
because the negative feedback loop works to restore homeostatic functioning, sustained levels of 
increased ACTH leads to decreased cortisol production.  Hence, chronic or severe exposure to 
trauma, including combat exposure, may produce enduring physiological effects, whereby 
continuous effort of the HPA axis to respond to trauma/stress and restore homeostatic functioning 
results in chronically high levels of ACTH, which in turn, result in lower levels of cortisol at 
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resting states.  Furthermore, maladaptive functioning of the HPA system has been shown to occur 
via numerous mechanisms, including unnecessary activation, lack of activation, or lack of 
termination (Handwerger, 2009).  These differential responses in physiological functioning could 
potentially account for the contradictory findings regarding baseline ACTH and cortisol within 
the extant literature.    
Variation in assessment methodology is a likely contributor to the conflicting results 
concerning neuroendocrine activity in individuals with and without PTSD.  Cortisol and ACTH 
fluctuate on a diurnal rhythm, wherein healthy individuals, levels peak in the early morning and 
become lowest when nearing the beginning of the sleep period (Desir et al., 1980).  Consideration 
of this fluctuation with regard to assessment is crucial, as assessments conducted at differing 
times of day may result in misleading variations in baseline results.  While both cortisol and 
ACTH should ideally be assessed at a standardized point within the diurnal pattern (e.g., early 
morning, when levels are highest in intra-individual stability; Pruessner et al., 1997), external 
factors, such as participant scheduling, study design, and methodology do not always allow for 
such control.  Therefore, samples obtained at varying time points may result in inconsistent 
results, particularly when neuroendocrine activity is being assessed under basal conditions.  
In addition to the temporal issues surrounding the assessment of HPA axis activity, 
variations in assessment mediums may account for some of the contradictory findings within the 
cortisol/ACTH literature.  Unlike ACTH, which is restricted to blood-based assessment only, 
cortisol may be assessed via several pathways.  Cortisol is most commonly assessed via saliva, 
urine, or plasma, but may also be assessed via cerebrals spinal fluid (CSF).  Each of these 
pathways, however, do not reflect cortisol in a standardized manner.  For example, whereas 
plasma and saliva samples mediate cortisol levels 1-2 hours prior to the assessment (Baum & 
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Grunberg, 1995), urine samples are usually collected over a 24-hour period to account for diurnal 
variation (Handwerger, 2009).  Consequently, results may vary depending on the sample method 
used.  For example, Levine and colleagues (Levine, Zagoory-Sharon, Feldman, Lewis, & Weller, 
2007) caution researchers when comparing salivary measurements to other sampling methods, 
demonstrated by the decrease in salivary cortisol when converted to cortisone by 11-beta-
hydrosteroid dehydrogenase type 2. 
Another possible explanation for the contradictory findings suggesting higher levels of 
baseline cortisol in individuals with PTSD could be described by time elapsed since trauma.  For 
example, some studies demonstrate increases in cortisol in the period directly following exposure 
to trauma (Bremner, 2001).  Cortisol has additionally been shown to increase in response to acute 
stress among individuals with PTSD (Bremner et al., 2003).  Thus, studies examining PTSD-
positive individuals who have experienced multiple or sustained traumas have not found evidence 
for a significant relationship between PTSD-positive status and lower baseline levels (Lemieux & 
Coe, 1995; Pitman & Orr, 1990).  This evidence could help explain why PTSD-positive 
individuals with consistent exposure to trauma or acute stress fail to display lower baseline 
cortisol levels.  Handwerger and colleagues (2009) offer a physiological explanation for this for 
lack of lower basal cortisol output among PTSD individuals exposed to multiple 
traumas/stressors.  They posit that, although the majority of studies report lower basal cortisol in 
PTSD, individuals with PTSD often display decreased hippocampal volume, typically associated 
with increased exposure to glucocorticoids, as evidenced by previous research (e.g., Bremner, 
Randall, et al., 1995; Gurvits et al., 1996).  Thus, although PTSD may result in lower output of 
cortisol over time, sustained exposure to stress or trauma will continue to result in higher 
glucocorticoid (e.g., cortisol) output, even at baseline.   
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Handwerger et al. (2009) acknowledge that some evidence in the literature demonstrates 
lower cortisol levels in the “immediate aftermath” of trauma (McFarlane, Atchison, & Yehuda, 
1997; Yehuda, Resnick, Schmeidler, Yang, & Pitman, 1998), but counter argue that obtaining 
neuroendocrine samples immediately following trauma is impossible and, thus, that cortisol 
samples collected during medical examination following a trauma may not actually be 
representative of cortisol levels present at the actual time of trauma.  Hence, individuals who go 
on to develop PTSD may exhibit significantly higher cortisol levels immediately following 
exposure to trauma and, additionally, may exhibit significantly higher cortisol levels during 
traumatic reminders.  These sustained or repeated high levels of cortisol may result in lasting 
glucocorticoid assault on the hippocampus (Handwerger, 2009).    
Another explanation for inconsistent findings regarding HPA functioning in relation to 
PTSD involves issues concerning control groups.  As previously discussed, Morris et al. (2012) 
propose the inclusion of TE individuals into control groups could be contributing to the 
inconsistent findings.  Studies that have analyzed separate TE and NTC groups have reported 
conflicting results.  Some studies have found neuroendocrine alterations following trauma 
irrespective of psychopathological diagnosis (De Kloet et al., 2007; Klaassens, Giltay, van Veen, 
Veen, & Zitman, 2010; Klaassens et al., 2009; Klaassens, van Veen, et al., 2010), whereas other 
studies have demonstrated changes in HPA functioning following trauma in relation to PTSD 
(Griffin, Resick, & Yehuda, 2005; Klaassens et al., 2012; Wessa et al., 2006; Yehuda et al., 
2002). 
 
Statement of the Problem 
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 Ubiquitous rates of trauma exposure are seen in both civilian and veteran populations 
(e.g., Breslau et al., 1998; Hoge et al., 2004), and are associated with a number of debilitating 
mental health conditions, including PTSD (Amstadter et al., 2013).  Numerous psychosocial 
factors, such as sleep (Maher et al., 2006), social support (Tsai et al., 2012), and trauma load 
(Dohrenwend et al., 2006) are related to risk for PTSD, and may also be related to HPA axis 
function.  Indeed, biological factors are also essential in understanding PTSD etiology, 
accounting for approximately one third of the variance (Amstadter et al., 2012).  Of biologic 
systems investigated in relation to PTSD, the HPA axis has received much attention and is a 
commonly implicated system in the etiology of PTSD (Yehuda, 2000).  Although the extant 
literature provides an abundance of important data on HPA axis biomarkers in relation to PTSD, 
studies examining basal cortisol and ACTH in a three group design (PTSD, TE, NTC) are less 
common and findings are highly variable.  Additionally, cortisol and ACTH are infrequently 
assessed within the same sample and few studies have investigated these associations in 
OIF/OEF/OND veterans.  The disparate findings stemming from a plethora of investigations is 
likely the result of several methodological issues (e.g., standardization, various assessment 
mediums, study design), but could also potentially be explained by a lack of examination of key 
moderators that may influence the relationship between PTSD and neuroendocrine markers.   
Although previous researchers have examined the associations between PTSD and key 
psychosocial and environmental variables such as social support, sleep, and trauma load, no 
studies to our knowledge have simultaneously investigated these factors as potential moderators 
of the relationship between PTSD and basal neuroendocrine levels.  For example, although social 
support has been evidenced as a dominant risk factor for PTSD, as well as an influential factor in 
neuroendocrine reactivity following stress (Kirschbaum et al., 1995; Ozbay et al., 2008; Steptoe 
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et al., 2004), no studies to our knowledge have examined the influence of social support on the 
relationship between PTSD and HPA-axis activity. 
The present study utilized data from an ongoing R01 (AA020179; PI Amstadter), which 
examines the effects of trauma on stress reactivity and subsequent drinking behavior in 
OIF/OEF/OND veterans aged 21-40 years old, to test whether genetic variation mediates these 
relationships.  This unique sample provides valuable data on psychosocial factors and basal 
neuroendocrine activity among a young military population, one which is largely comprised of 
individuals at highest risk for combat exposure (Hoge et al., 2004).   
 
Aims and Hypotheses 
The present study aimed to compare baseline neuroendocrine levels by trauma group 
(PTSD, TE, NTC) among a sample of OIF/OEF/OND veterans.  More specifically, the main aim 
was to examine basal cortisol and ACTH to test whether levels differ significantly by trauma 
group.  Based on the effects of the HPA axis negative feedback loop, wherein chronically 
elevated levels of ACTH may result in lower basal cortisol, it was hypothesized that individuals 
in the PTSD group will demonstrate significantly lower cortisol levels at baseline, compared to 
both TE and NTC groups.  Considering the HPA axis among individuals with PTSD may operate 
as it would in response to stress in healthy individuals at resting conditions suggests a sustained 
production of ACTH, even at baseline.  Therefore, it was hypothesized that individuals in the 
PTSD group would demonstrate significantly higher baseline ACTH levels than those in the TE 
and NTC groups.  However, due to the negative feedback loop within the HPA axis, wherein 
increased ACTH should signal the termination of cortisol release to return to homeostasis, it was 
hypothesized that lower levels of cortisol at resting state among individuals with PTSD may be 
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found.  Based on common findings in the extant literature, it was hypothesized that basal 
neuroendocrine levels would not differ between the TE and NTC groups, suggesting a unique 
contribution of HPA axis activity to PTSD.   
A second, exploratory aim of this study was to examine factors that may moderate the 
relation between PTSD symptom severity and basal neuroendocrine levels.  Given the robust 
effect sizes for social support demonstrated in the PTSD literature, which suggest that social 
support is among the strongest predictors of PTSD following trauma (e.g., Brewin et al., 2000), as 
well as the evidenced effects of social support on neuroendocrine activity (e.g., Ozbay et al., 
2008), it was hypothesized that deployment unit social support and post-deployment social 
support would moderate the relationship between PTSD symptom severity and basal cortisol and 
ACTH, serving as a buffer between PTSD and neuroendocrine activity, such that higher levels of 
social support would weaken the inverse relationship between PTSD and basal cortisol and 
weaken the positive relationship between PTSD and ACTH.    
Additionally, given the distinct relationships between both sleep and PTSD, as evidenced 
by the high prevalence of sleep disturbance symptoms among individuals with PTSD, and sleep 
and the HPA-axis, as evidenced by the importance of the HPA-axis in sleep onset, maintenance, 
and awakening, sleep is a discernable variable which may act to influence the relationship 
between PTSD severity and HPA-axis activity.  If disturbed, sleep is associated with both 
increased PTSD severity and HPA-axis dysregulation; poor sleep quality may serve to influence 
the relationship between PTSD and HPA-axis activity.  Thus, it was hypothesized that sleep 
disturbance would moderate the relationship between PTSD symptom severity and cortisol and 
ACTH, such that higher sleep disturbance would strengthen the inverse relationship between 
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PTSD and basal cortisol and strengthen the positive relationship between PTSD and symptom 
severity ACTH. 
Furthermore, as demonstrated in the literature, cumulative effects of trauma have 
profound effects on psychopathology and physiological functioning.  Therefore, given the low 
conditional risk for PTSD, examination of trauma exposure, regardless of psychological 
diagnosis, is critical in elucidating whether the effects of PTSD symptom severity on HPA-axis 
activity are influenced by cumulative trauma load. To that end, as a result of the powerful 
influence of cumulative trauma load on subsequent physical and mental health functioning, it was 
hypothesized that trauma load would moderate the relationship between PTSD and basal cortisol 
and ACTH, such that higher levels of combat severity and lifetime trauma load would strengthen 
the inverse relationship between PTSD and cortisol and strengthen the positive relationship 
between PTSD and ACTH.    
 
 
 
Method 
 
Overview of the Study 
 The present study included data from 155 participants from a larger ongoing study 
examining the effect of trauma on stress reactivity and subsequent drinking behavior in 
OIF/OEF/OND veterans (R01 AA020179; PI Amstadter).  Data collection began in the winter of 
2011, and will continue until June 2016. Potential participants were screened via telephone or 
REDCap.  REDCap is a secure web-based application designed exclusively to support data 
capture for research studies (Harris et al., 2009).  Individuals meeting basic eligibility criteria 
completed an office visit assessment, and those meeting final eligibility criteria were brought to 
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the Clinical Research Services Unit (CRSU) to complete the lab visit.  Half of participants from 
each group were randomized to receive the Trier Social Stress Test (TSST); the other half 
received a no-stress control condition.  Baseline and post-stress objective and subjective measures 
of stress reactivity were collected.  Following the stress task, all participants received a “priming 
dose” of alcohol, followed by a deceptive “taste test” task, where amount of alcohol consumed 
served as the primary dependent variable for the parent study.  The Virginia Commonwealth 
University and Richmond McGuire VA Institutional Review Boards approved all study 
procedures and informed consent was obtained from all study participants.  Data for the present 
study included information from the clinical interview and self-report assessments administered 
in the office session, as well as the baseline neuroendocrine assessments from the lab session.   
 
Recruitment 
 Participants were recruited through the community, as well as the university and Veteran’s 
hospitals, by advertising (e.g., flyers, internet), and through collaborations with other researchers.  
Mailings were distributed to local veterans within the 21-40 year old age range via the local 
Veteran’s hospital.  Mailed materials included study brochures and an “Initial Contact” cover 
letter, used to inform potential participants that they may be called by research staff and provide a 
phone number that the recipient could call to confirm that the study constitutes VA research, as 
well as a phone number that recipients could call to “opt out” of future contact.  Individuals who 
“opted out” were removed from future mailing and calling lists for the parent study.  In addition 
to the mailings, calls to potential participants were made after sending the brochure and the initial 
contact letter. Interested individuals completed an eligibility screener for major inclusion and 
exclusion criteria via the telephone or online through REDCap. 
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Inclusion/Exclusion Criteria 
Inclusion criteria for the parent study included an age between 21-40 years old and the 
ability to provide informed consent.  Because alcohol was administered in the parent study, 
participants had to be regular drinkers (i.e., drink alcohol on at least 4 days in the month prior to 
the screener) and drink beer, but could not meet DSM-IV criteria for current alcohol dependence 
nor be seeking treatment for alcohol dependence.  Exclusion criteria included history of a 
moderate or severe traumatic brain injury (TBI), the presence of a condition that affected HPA-
axis functioning (e.g., individuals taking psychoactive medications, antihistamines, or anti-
inflammatory medications; alcohol dependence; Major Depressive Disorder; hypertension, 
chronic pain, Addison’s disease) and factors that would affect stress or stress hormones (e.g., 
smokers who could not abstain from smoking for at least 4 hours, severe obesity [i.e., BMI ≥ 
40]).  With the exception of nicotine and caffeine, and possibly marijuana (if the participant could 
abstain), participants could not be dependent on other drugs.  Additionally, pregnant or nursing 
women, or women who suspected they may be pregnant were excluded from participation.  
Individuals with any blood clotting disorder were also excluded due to the blood draw component 
of the study.  
   
Eligibility Screening 
The eligibility screener, which was administered via telephone or via an online screening 
tool, assessed for age, past month drinking status and preference, potential alcohol dependence, 
presence of a TBI, presence of conditions that affect HPA-axis functioning, factors that affect 
stress or stress hormones, and disorders that affect blood clotting.  The screener also assessed 
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potential substance use disorder and past month drug use.  Women were queried about the 
potential of pregnancy or nursing.  In total, 863 screeners have been conducted to date, with 275 
individuals qualifying for the office visit.  Major reasons for disqualification include use of 
psychoactive medications and MDD.   
 
Participants 
 Descriptive statistics for the parent study sample.  The parent study sample (i.e., 
participants who completed at least the office visit) was comprised of 236 participants (89.6% 
male; Mage=29.28, SD=4.28).  The sample was comprised of participants who self-identified as 
White (76.2%), Black (15.8%), and Other (7.9%).  48% of participants had never been married at 
the time of assessment, 13.4% were separated/divorced, 34.2% were married or cohabitating, and 
0.5% were widowed.  7.4% of participants were high school or GED graduates.  Over half of the 
sample had completed some college (55.4%), 24.9% were college graduates, and 8.4% had 
completed more than a bachelor’s degree.  The majority of the sample had an annual income of 
$50,000 or less (71.3%). 
Descriptive statistics for the present study sample.  Not all participants who complete 
the office visit qualify for the laboratory visit. In order to be included in the present study, 
participation in both sessions was required, as neuroendocrine data are collected at the second 
study visit.  Descriptive statistics from the present study sample closely mirror those from the 
parent study sample, as they represent a proportion of the larger parent sample.  The sample for 
the present study was comprised of 155 participants (90.3% male; Mage=29.36, SD=4.31).  
Because stricter criteria were used to determine group status, analyses examining the effects of 
trauma group will have a smaller sample size (N=117).  Said groups were categorized as PTSD 
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(n=32), TE (n=51), or NTC (n=34).  Additionally, PTSD symptom severity was determined using 
the DSM-IV diagnostic criteria, rather than the extreme discordant severity score criteria to 
determine group status.  Therefore, analyses examining the predictive effects of PTSD symptom 
severity will be conducted with a more inclusive sample (N=155).   
The restricted sample used for analyzing trauma group differences (N=117) was 
comprised of participants who self-identified as White (75.0%), Black (15.4%), and Other 
(9.6%).  46.3% of participants had never been married at the time of assessment, 16.9% were 
separated/divorced, 35.3% were married or cohabitating, and 1.5% were widowed.  8.8% of 
participants were high school or GED graduates.  Over half of the sample had completed some 
college (52.9%), 28.7% were college graduates, and 9.6% had completed more than a bachelor’s 
degree.  The majority of the sample had an annual income of $50,000 or less (75.7%).  The 
majority of the sample had an annual income of $50,000 or less (74.6%).  The majority of 
individuals in the total sample had served in the Army (58.8%), followed by Marines (14.0%) and 
Navy (8.8%).  Most participants in the total sample had served as Enlisted soldiers, with the 
majority ranked from E-4 to E-6 (81.6%).   
The more inclusive sample used for analyzing PTSD symptom severity (N=155) was 
comprised of participants who self-identified as White (76.7%), Black (14.0%), and Other 
(9.3%).  45.3% of participants had never been married at the time of assessment, 14.7% were 
separated/divorced, 39.3% were married or cohabitating, and 0.7% were widowed.  8% of 
participants were high school or GED graduates.  Over half of the sample had completed some 
college (56%), 26.7% were college graduates, and 9.3% had completed more than a bachelor’s 
degree.  The majority of the sample had an annual income of $50,000 or less (74.6%).  The 
majority of individuals in the total sample had served in the Army (57.3%), followed by Marines 
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(17.3%) and Army National Guard (8.7%).  Most participants in the total sample had served as 
Enlisted soldiers, with the majority ranked from E-4 to E-6 (80.7%).  Data for the present study 
was frozen on 08/21/2015. 
 
Procedures 
 Office session.  Individuals meeting preliminary criteria came in for an office visit.  The 
office visit included the provision of informed consent, a clinical interview, and a battery of self-
report measures to assess combat exposure, traumatic event exposure history, alcohol use, 
lifetime and past month PTSD, and other psychopathology and psychological characteristics.  The 
majority of the structured clinical interviews were conducted by post-doctoral fellows; however, 
some interviews were conducted by MSWs and advanced doctoral psychology students.  All 
interviews were recorded on audiotape and will be assessed to determine inter-rater reliability.  
Following the office visit, participants who did not meet criteria for the second session were 
compensated for their time.  Reasons for disqualification following the office session included a 
diagnosis of past but not current PTSD or other comorbidities, such as a diagnosis of any Axis I 
disorder.  Of the 297 individuals who completed the eligibility screen and qualified for the office 
session, 234 completed the office session. Of the participants who completed the office session, 
71% qualified for the laboratory visit, and 68% completed the laboratory session.  Of the 
participants who qualified for the laboratory visit, 96% completed it.  Of the 4% of participants 
who qualified for the laboratory visit but did not participate in it, 1 declined to participate due to a 
family conflict, 1 was called to Active Duty, 1 decided to quit drinking alcohol, and 4 were lost to 
follow-up.   
 Group assignment.  To be eligible for the Non-Trauma Control (NTC) group, 
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participants could not have a history of a Criteria A traumatic event (combat or otherwise; DSM-
IV Criteria A requires that the person has experienced, witnessed, or been confronted with an 
event or events that involve actual or threatened death or serious injury, or a threat to the physical 
integrity of oneself or others, and that the person’s response involved fear, helplessness, or horror; 
American Psychiatric Association, 1994).   
 To be eligible for the Combat Trauma Exposed group (TE), participants must have had a 
history of a Criteria A combat traumatic event during OIF/OEF deployment, but not have met the 
DSM-IV criteria for PTSD (Current or Lifetime), as defined by a Clinician Administered PTSD 
Scale (CAPS) score of < 19. If individuals endorsed more than one form of combat traumatic 
event exposure, the combat event personally deemed the “worst” was used as the index trauma. 
Other than the time frame of OIF/OEF deployment, there was no restriction on the timing of the 
“worst” trauma.  No restriction on the timing of the trauma was decided based on data that clearly 
indicates that PTSD can result from both recent (within the past year) and distant (greater than 
one year) TE exposure (Teicher et al., 2003; Waldrop, Santa Ana, Saladin, Brady, & McRae, 
2007; Weems & Carrion, 2007).   
 To be eligible for the PTSD group, participants must have had a history of combat trauma, 
meeting Criteria A, and have met current criteria for PTSD, as defined by DSM-IV (exposure to a 
Criteria A event, endorsement of at least 1 cluster B symptom, 3 or more cluster C symptoms, at 
least 2 cluster D symptoms, and functional impairment) and a CAPS severity score of > 45.  
Laboratory session instructions. Eligible participants were instructed not to eat after 
noon on the day of their scheduled laboratory visit, and to avoid caffeine on that day, as both food 
and caffeine can introduce noise variability to the neuroendocrine response to the stressor.  If the 
individual was a smoker, he/she was asked to smoke his/her last cigarette between 3:00 and 4:00 
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pm on that day, to prevent nicotine withdrawal that might influence neuroendocrine activity.  
Participants were also instructed to avoid alcohol in the 48 hours prior to the test date.  
Additionally, participants were cautioned to abstain from use of drugs in the weeks prior to the 
challenge day, as they would need to pass a urine drug test on the challenge day.  Women were 
scheduled for the laboratory session during the follicular phase of their menstrual cycle, which is 
the period of the menstrual cycle when both estrodial and progesterone are low; testing all women 
during this phase served to reduce variability within women and between the genders.   
 
Laboratory Session 
Participants meeting inclusion criteria were urn randomized by gender and at-risk drinking 
to receive either the stress condition or the no-stress condition for the aims of the parent study.  
Urn randomization allows for equal distribution between experimental conditions, as it decreases 
the probability of being assigned to a certain experimental group if the group is overrepresented 
and vice versa (i.e., the more individuals in the stress condition, the less likely the next participant 
is to be randomized into that condition; Schulz & Grimes, 2002).   
The individual arrived at the clinical research services unit (CRSU) at 4:00 pm on the 
challenge day, at which time, (s)he was breathalyzed and asked to provide a urine sample, which 
was tested for presence of marijuana, opiates, barbiturates, benzodiazepines, and stimulants. For 
female participants, a pregnancy test was administered (to ensure safety of the alcohol 
administration component of the parent study).  When both tests came back negative, the 
participant was fitted with an indwelling catheter to facilitate blood draws (which were assayed 
for ACTH and cortisol) and a blood pressure cuff at approximately 4:15 pm. The participant 
acclimated for one hour to the testing room (4:00 to 5:00pm). Two baseline assessments of stress 
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response measures were collected: one at approximately 4:40pm and the second at approximately 
4:55pm.  Subjective units of distress (SUDS), blood pressure and heart rate were also assessed at 
baseline.  
Parent study procedures.  Figure 1 shows the experimental procedures and assessments 
collected at each time point during the laboratory visit for the full parent study.  Notably, 
however, only data from the baseline assessments collected at 4:55pm were used in the present 
study. The decision to use the second baseline assessment was made to allow for further 
acclimation following the fitting of the indwelling catheter, with the aim of obtaining data that 
most closely resembles cortisol and ACTH at “resting state”.  
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Time   Exp Procedure   Stress Assessments 
4:40    Cortisol; BP, HR, SUDs 
4:55    ACTH & Cortisol; BP, HR, SUDs 
5:00  
TSST or control 
   
5     
10     
5:15    ACTH & Cortisol; BP, HR, SUDs 
20  
Priming dose 
   
25     
5:30  
 
ACTH & Cortisol; BP, HR, SUDs, BAES, DEQ, 
BAL; Balance 
35      
40      
5:45  
Taste Task 
 Cortisol; BP, HR, SUDs, BAL 
50     
55     
6:00   Cortisol; BP, HR, SUDs, BAES, DEQ, BAL 
6:30    Cortisol; BP, HR, SUDs, BAL; Balance 
7:00    Cortisol; BP, HR, SUDs, BAL; Attitudes 
7:15    BAL 
7:30       BAL 
Figure 1. Overview of Laboratory Session Procedures 
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Dismissal.  A breath alcohol analyzer was used to confirm that the reading was 10 mg% 
or lower prior to dismissal. All participants were given an information packet that includes 
information about services related to assessment and treatment of PTSD and related conditions. 
 
Measures 
 Demographics.  A demographics form was used to assess participant gender, race, 
ethnicity, marital status, education, annual income, employment status, military status, and 
smoker status.  Age, weight, and height were also assessed, in addition to military branch, rank, 
and status.  Information regarding participant deployments was obtained in the demographics 
form, as well as information regarding post-deployment difficulties and resources.  Race and 
ethnicity were dummy coded into a “White, Non-Hispanic vs. other” variable, which was entered 
into the model.   
 Clinician Administered PTSD Scale (CAPS) (Blake et al., 1990).  The CAPS is a 
diagnostic interview for current and lifetime PTSD.  The CAPS demonstrates high inter-rater 
reliability (i.e., above .86) and internal consistency on each of the three PTSD symptom clusters 
(range .63 to .89), and correlates strongly (i.e., above .61) with other measures of PTSD (Hovens 
et al., 1994; Hyer, Summers, Boyd, Litaker, & Boudewyns, 1996).  Since the beginning of the 
study, the APA released the DSM-V that included changes to the PTSD criteria. However, 
eligibility was still based on DSM-IV criteria.  Total internal consistency for this measure within 
the present sample was .87. Internal consistency for the re-experiencing subscale within the 
present sample was .73. Internal consistency for the avoidance subscale within the present sample 
was .78. Internal consistency for the hyper-arousal subscale within the present sample was .65. 
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Mini-International Neuropsychiatric Interview (MINI) (Lecrubier et al., 1997). The 
clinician-delivered structured clinical interview (MINI version) using DSM-IV criteria was used 
to assess potential participants for presence of exclusionary major Axis I disorders as well as to 
confirm eligibility for individuals in the PTSD group.  This measure demonstrates excellent inter-
rater reliability, with all kappa values above 0.75 and the majority over 0.90 or higher.  
Furthermore, the majority of kappas for test-retest reliability were above 0.75, indicating very 
good test-retest reliability (Sheehan et al., 1997).   
The Life Events Checklist (LEC) (Gray, Litz, Hsu, & Lombardo, 2004). The LEC 
assesses trauma exposure history, including a list of 17 potentially traumatic events (e.g., sexual 
assault, physical assault). Participants indicate whether they have experienced each event, have 
witnessed the event happening to someone else, or have learned about the event happening to 
someone close to them.  The LEC has been shown to have a mean kappa of .61 and a retest 
correlation of r = .82, p < .001 (Gray et al., 2004). 
The Deployment Risk and Resiliency Inventory (DRRI) (King, King, & Vogt, 2003). 
The DRRI is a series of scales assessing 14 key deployment-related risk and resilience factors 
with demonstrated implications for veterans' long-term health including the veteran’s exposure to 
various combat-related experiences, level of social support prior to and following deployment and 
the effect of deployment on family life.  Estimates of internal consistency reliability were .85 or 
higher for all DRRI scales (Vogt, Samper, King, King, & Martin, 2008).  The Unit Social Support 
Scale (USS) and Post-deployment Social Support Scale (PSS) was used to examine deployment 
and post-deployment social support in the moderation analyses.  Internal consistency for the USS 
subscale in the present sample was .90.  Internal consistency for the PSS subscale in the present 
sample was .85.  The Combat Experiences Scale (CES) was used to examine combat trauma load 
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and the Pre- and Post-deployment stressful event scales were aggregated to assess lifetime trauma 
load in the moderation analyses.  Internal consistency for the Combat Experience Scale (CES) 
within the present sample was .88. Internal consistency for Lifetime Trauma Load within the 
present sample was .73. 
Pittsburg Sleep Quality Index (PSQI) (Buysse et al., 1989).  The PSQI is a self-report 
instrument that measures sleep quality and disturbance over a 1-month period (Carpenter & 
Andrykowski, 1998). The PSQI has 9 questions and 19 items. All scores are combined to derive a 
Global PSQI Score. There are seven subscales: subjective sleep quality, sleep latency, sleep 
duration, habitual sleep efficiency, sleep disturbances, use of sleep medications, and daytime 
functioning. The PSQI has an item that queries nightmares. Clinically meaningfully disturbed or 
poor sleep of the insomnia type is indicated with Global PSQI Scores above 5 (<5 are considered 
normal, 6-10 = moderately impaired sleep; >11 = severely impaired sleep). The Global PSQI 
score was be used to examine sleep disturbance in the analyses. Internal consistency for this 
measure within the present sample was .76. 
Subjective Units of Distress (SUDs) (Wolpe, 1958) is a self-report instrument designed 
to measure subjective distress levels on a scale of no distress at all (0) to extreme distress (10) 
following a potentially anxiety provoking stimuli. The measure was assessed numerous times 
throughout the study.  SUDs was examined as a potential covariate if trauma groups differ at 
baseline. 
ACTH and cortisol assays. Blood samples for buffy coat and plasma storage were 
collected in 1 x 10 ml standard EDTA tubes.  Plasma was separated from cells by centrifugation, 
and the serum samples were stored at -80 C until thawed for assay.  Cortisol and ACTH were 
assayed using the ELISA immunoassay system (ALPCO Diagnostics, Salem, NH).   
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Data Analytic Plan 
 Post hoc statistical power analyses were conducted using G*Power software (Faul, 
Erdfelder, Buchner, & Lang, 2009) for the proposed hypotheses.  The power to detect a medium-
sized effect (f=.25; Cohen, 1988) for the MANOVA at an alpha level of .05 in the present sample 
was determined to be >.99.  Considering tests of moderation are traditionally low in power, a 
power analysis was also conducted for the exploratory aim, with the effect size anticipated for the 
moderator effect (i.e., the anticipated incremental variance explained by the joint effect above and 
beyond the additive effects).  The power to detect a medium-sized moderator effect (f2=.15; 
Cohen, 1988) at an alpha level of .05 in the present sample was determined to be >.99.   
First, all variables were assessed for univariate normality and for outliers.  Second, key 
demographic variables (e.g., age, race/ethnicity, sex) were examined in relation to cortisol and 
ACTH levels to test for inclusion as possible covariates in the tests of group differences and in the 
regression analyses. To address the primary aim, two one-way analyses of variance (ANOVAs) 
were conducted, one with cortisol as the dependent variable and one with ACTH as the dependent 
variable. The independent variable in both ANOVAs was trauma group (PTSD, TE, NTC).  In the 
presence of a nominally significant ANOVA, post-hoc testing was conducted to determine which 
groups were driving the effects.  
To address the exploratory aims, ten separate hierarchical regression analyses were 
conducted within the more inclusive sample (N=155), one regression for each potential moderator 
for each neuroendocrine marker.  First, two hierarchical regression analyses were conducted to 
evaluate the hypothesized influence of unit social support during deployment on the relation 
between PTSD and basal neuroendocrine levels with cortisol and ACTH as the dependent 
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variables.  Second, two hierarchical regression analyses examined the influence of post-
deployment social support on the relation between PTSD and cortisol and ACTH.  Third, two 
hierarchical regression analyses were conducted to evaluate the hypothesized influence of sleep 
disturbance on the relation between PTSD and basal neuroendocrine levels with cortisol and 
ACTH as the dependent variables.  Fourth, four hierarchical regression analyses were conducted 
to evaluate the hypothesized influence of trauma load (two regressions examining combat 
severity and two regressions examining lifetime trauma load) on the relation between PTSD and 
basal neuroendocrine levels with cortisol and ACTH as the dependent variables. Prior to the 
analyses, the independent and moderator variables were centered and a product term created from 
the centered variables (Baron & Kenny, 1986).  Significant demographic variables were 
controlled for in step 1, PTSD symptom severity was entered independently in step 2, the additive 
effects were entered in step 3, and the product term was entered in step 4 of the model. Correction 
for multiple testing was done via a Bonferroni adjustment. 
 
 
 
Results 
 
 
Descriptive Statistics 
 Descriptive statistics by group can be found in Table 1.  The mean age of participants in 
the total sample (N=155) was 29.36 (SD=4.31), and the majority of participants were male 
(90.3%), and 74.2% were white/non-Hispanic.  
The NTC (n=34), TE (n=51), and PTSD (n=32) groups did not differ among any 
demographic variables, but were significantly different with regards to a number of other 
variables.  By design of the inclusion and exclusion criteria, the group means differed 
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significantly for PTSD symptom severity, F (2, 97 = 137.43, p < .001, partial =.75, with the 
NTC (M = 9.83, SD = 5.36) and TE (M = 10.12, SD = 8.32) groups having significantly lower 
scores than the PTSD group (M = 52.18, SD = 17.11, p < .001).  Expectedly, mean scores of 
PTSD symptom severity did not differ significantly between NTC and TE groups (p = .997).  
Trauma group means also differed significantly for post-deployment social support, F (2, 120) = 
6.93, p = .001, partial =.10.  Notably, lower scores on the PSS subscale indicated greater 
endorsement of support.  Thus, individuals in the TE (M = 30.37, SD = 8.58) group endorsed 
significantly higher levels of post-deployment social support than the PTSD group (M = 35.58, 
SD = 9.23, p = .021).  NTC post-deployment social support levels (M = 29.17, SD = 6.66) did not 
significantly differ from those of the PTSD group (p = .075) or from the TE group (p = .901).   
Additionally, trauma group means differed according to combat exposure severity, F (2, 
120) = 8.35, p < .001, partial =.12, with individuals in the TE (M = 5.54, SD = 3.44) group 
reporting significantly lower combat exposure severity than the PTSD group (M = 8.18, SD = 
3.92, p = .005).  Notably, however, combat exposure severity levels in the NTC group (M = 6.0, 
SD = 3.95) did not significantly differ from those in the PTSD group (p = .188).  Mean scores of 
combat exposure severity did not differ significantly between NTC and TE groups (p = .919).  
Furthermore, group means differed significantly for lifetime trauma load, F (2, 120) = 11.45, p < 
.001, partial =.16, with the NTC (M = 3.08, SD = 2.31) and TE (M = 6.31, SD = 3.82) groups 
endorsing significantly lower lifetime trauma load than the PTSD group (M = 8.45, SD = 3.30, p 
< .001, p = .019, respectively).  Mean scores of lifetime trauma load also differed significantly 
between NTC and TE groups (p = .014).  Lastly, trauma group mean scores for sleep disturbance 
differed significantly, F (2, 120) = 13.19, p < .001, partial =.18, such that individuals in the 
NTC (M = 4.08, SD = 1.98) and TE (M = 6.0, SD = 3.66) groups endorsed significantly lower 
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sleep disturbance than individuals the PTSD group (M = 9.42, SD = 3.41, p < .001 for both 
comparisons).  Mean scores of sleep disturbance did not differ significantly between NTC and TE 
groups (p = .192).   
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Table 1.  
 
Descriptive Statistics by Trauma Group 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note:  
a  Significant difference between NTC and TE 
 Control (n=34) TE  
(n=51) 
PTSD 
(n=32) 
Total 
 
Variable Mean (SD) Mean (SD) Mean (SD) F p 
Age 29.50 (3.93) 30.76 (4.32) 29.78 (5.00) .874 .421 
PTSD Symptom Severity  9.83 (5.36) 9.6 (7.55) 52.97 (16.76) 154.28 .000b,c 
Trauma Load 4.65 (3.41) 6.31 (3.85) 8.56 (3.29) 11.14 .000a,b,c 
PSQI 5.35 (3.09) 5.92 (3.65) 9.50 (3.44) 15.43 .000b,c 
PSS 29.53 (7.33) 30.25 (8.62) 36.00 (9.04) 5.21 .007b 
USS 
CES 
28.41 (10.04) 
4.50 (3.57) 
0.21 (0.23) 
31.45 (10.76) 
5.49 (3.46) 
0.19 (0.23) 
30.34 (10.82) 
8.03 (3.88) 
0.31 (0.24) 
1.18 
4.81 
2.58 
.312 
.010b 
.081 SUDS 
 % % % Total 
X2 p 
Gender    5.95 .051 
Males 100 85.0 87.2   
Race    5.57 .234 
White 83.3 66.1 79.5   
African American 8.3 23.7 10.3   
Other 8.3 10.2 10.3   
Ethnicity    3.92 .141 
Hispanic 5.4 5.0 15.4   
Non-Hispanic 94.6 95.0 84.6   
Education    1.147 .979 
High School 8.3 8.5 10.3   
Some College 52.8 49.2 56.4   
College 30.6 32.2 23.1   
More Than College 8.3 10.2 10.3   
Marital Status    5.0 .544 
Never Married 44.4 42.4 53.8   
Separated /Divorced 11.1 23.7 12.8   
              Married or Cohabitating 41.7 32.2 33.3   
Widowed 2.8 1.7 0.0   
Military Branch    8.84 .841 
Army 55.6 50.8 71.8   
Marine Corps 13.9 16.9 10.3   
Navy 8.3 11.9 5.1   
Air Force 5.6 3.4 2.6   
Army National Guard 5.6 8.5 10.3   
Army Reserves 2.8 1.7 0.0   
Marine Reserves 5.6 5.1 0.0   
Military Rank    16.14 .583 
Enlisted 89.0 91.6 84.7   
Officer 11.0 8.4 15.3   
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b  Significant difference between TE and PTSD  
c  Significant difference between NTC and PTSD 
PSQI=Pittsburg Sleep Quality Index 
PSS= Post-deployment Social Support Scale 
USS= Unit Social Support Scale 
CES= Combat Experiences Scale 
SUDs= Subjective Units of Distress 
*p<.05;**p<.01;***p<.001 
 
 
Tests of Univariate Normality   
Prior to analyses, all variables were assessed for univariate normality.  Variables with 
violations in skewness or kurtosis, as defined by having an absolute z-value (skewness or 
kurtosis/standard error) over 3.29, were log-transformed (Kim, 2013).  Log-transformations were 
conducted for cortisol, ACTH, and SUDs.  Following log-transformation, one outlier on ACTH 
was removed for having a value that exceeded 3 standard deviations beyond the mean.  Notably, 
because the number of participants in each group was not equal and tests of ANOVA assume 
equal variances across groups, a hypothesis test was performed to validate the assumption, (i.e., 
Levene's Test) and showed that the assumption of homogeneity of variance was met for each 
group for both cortisol and ACTH, F (2, 117) = 2.772, p = .067; F (2, 115) = 2.189, p = .117, 
respectively.  Notably, these tests are not powerful to detect small deviations; however, they are 
able to detect larger deviations.  Additionally, deviation from heterogeneity of variance was 
checked by inspecting residual plots, which showed that all group variances approximated 
normality. 
 
Determination of Covariates for Trauma Group Difference Analyses   
The determination if covariates should be used (i.e., ANCOVA vs. ANOVA) was done in 
a two-step process. First, variables found to be significantly correlated with either cortisol or 
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ACTH within the restricted sample (n=117) were entered into two hierarchical linear regressions 
in order to determine the unique contribution of each potential covariate on both cortisol and 
ACTH.  Age was negatively associated with cortisol, r(115) = -.21, p = .025.  White/Non-
Hispanic status was negatively associated with ACTH, r(115) = -.16, p = .04.  Conversely, post-
deployment social support was positively associated with ACTH, r(115) = .20, p = .029.  Lifetime 
trauma load was negatively associated with cortisol r(115) = -.20, p = .03.  Lastly, SUDS was 
positively associated with cortisol, r(115) = .20, p = .027.  Second, significantly correlated 
variables  (i.e., age, white/non-Hispanic status, post-deployment social support, lifetime trauma 
load, and SUDs) were entered in the first step and trauma group was entered in the final step of 
each hierarchical regression (one predicting basal cortisol and one predicting ACTH).  Partial 
correlation coefficients were examined to determine the amount of variance estimated by each 
variable, independent of the variance estimated by other variables in the model.  Because all 
variables demonstrated small effect sizes (Cohen, 1988), no covariates were included and 
ANOVAs were conducted. 
 
Aim 1 Results: Examine Whether Baseline Cortisol and ACTH Differ by Trauma Group 
 
ANOVAs.  Two one-way analyses of variance (ANOVAs) were conducted, one with 
cortisol as the dependent variable and one with ACTH as the dependent variable. The 
independent variable in both analyses was trauma group (NTC, TE, PTSD).  The difference in 
levels of basal cortisol between trauma groups was nominally significant, F (2, 119) = 2.996, p = 
.054.  Because difference in basal cortisol showed a nominally significant p-value, post-hoc 
comparisons were conducted to determine from where the effect was driven.  Post-hoc 
comparisons using the Tukey HSD test indicated that the mean basal cortisol level for NTC 
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individuals (M = 9.94, SD = 5.33) was significantly higher than the mean basal cortisol level for 
individuals in the PTSD group (M = 7.01, SD = 2.34, p = .049).  The TE group (M = 8.34, SD = 
5.24) did not differ significantly from either the NTC (p = .18) or PTSD (p = .70) groups.  A 
second one-way ANOVA indicated that there was not a significant effect of trauma group on 
ACTH, F (2, 117) = .045, p = .96.   
 
Table 2. 
Correlations Between Study Variables Within the Total Sample 
 
*p<.05;**p<.01;***p<.001 
Note: USS= Unit Social Support Scale 
PSS= Post-deployment Social Support Scale 
CES = Combat Experiences Scale 
PSQI= Pittsburg Sleep Quality Index 
CAPS = Clinician Administered PTSD Scale 
 
 
Aim 2 Results: Examine Potential Moderators of the Relation between PTSD Symptom 
Severity and Neuroendocrine Activity 
 
Correlations among study variables are shown in Table 2. Variables significantly 
correlated with cortisol were controlled for in Step 1 of all of the models examining cortisol as the 
outcome variable (i.e., marital status and lifetime trauma load).  Lifetime trauma load was 
excluded as a covariate in the analysis examining lifetime trauma load as a potential moderator.  
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Similarly, factors significantly correlated with ACTH were controlled for in Step 1 of all of the 
models examining ACTH as the outcome variable (i.e., post-deployment social support).   
Social support.  Hierarchical regression analyses evaluated the hypothesized influence of 
social support on the relation between PTSD symptom severity and both basal cortisol and 
ACTH.  Neither unit social support nor post-deployment social support significantly moderated 
the relation between PTSD symptom severity and either cortisol or ACTH.  Lifetime trauma load 
was the only significant predictors of cortisol in the Step 4 for both USS and PSS, β = -.216, t 
(117) = -2.321, p = .022; β = -.224, t (117) = -2.448, p = .016, respectively.  No variables 
significantly predicted ACTH for either USS or PSS.  Please refer to Tables 3-6 for detailed 
results.   
 
Table 3.  
 
Post-Deployment Social Support - Cortisol 
 Cortisol  
Variable β SE t p ΔR2 
PSS      
Step 1     .089 
Lifetime Trauma Load 
Marital Status 
 
-.243 
-.171 
 
.005 
.019 
 
-2.79 
-1.97 
 
.006 
.052 
 
 
Step 2     .011 
Lifetime Trauma Load 
Marital Status 
PTSD Severity 
-.213 
-.174 
-.110 
.005 
.019 
.001 
-2.35 
-2.00 
-1.21 
.020 
.048 
.229 
 
Step 3     .003 
Lifetime Trauma Load 
Marital Status 
PTSD Severity 
PSS  
-.213 
-.169 
-.130 
.061 
.005 
.020 
.001 
.002 
-2.35 
-1.94 
-1.35 
.653 
.021 
.055 
.178 
.515 
 
Step 4     .006 
Lifetime Trauma Load 
Marital Status 
PTSD Severity 
PSS 
PSS*PTSD 
-.224 
-.168 
-.105 
.069 
-.085 
.005 
.020 
.001 
.002 
.000 
-2.45 
-1.92 
-1.05 
.736 
-.918 
.016 
.057 
.298 
.463 
.361 
 
*p<.05;**p<.01;***p<.001 
Note: PSS = Post-Deployment Social Support 
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Table 4.  
 
Post-Deployment Social Support - ACTH 
 ACTH  
Variable β SE t p ΔR2 
PSS      
Step 1     .000 
PTSD Severity -.003 .001 -.028 .977  
Step 2     .016 
PTSD Severity  
PSS 
-.050 
.135 
.001 
.003 
-.515 
1.40 
.607 
.163 
 
Step 3     .004 
PTSD Severity  
PSS  
PSS*PTSD 
-.033 
.140 
-.067 
.001 
.003 
.000 
-.328 
1.45 
-.711 
.744 
.150 
.479 
 
*p<.05;**p<.01;***p<.001 
Note: PSS = Post-Deployment Social Support 
 
 
Table 5.  
 
Unit Social Support – Cortisol  
 
*p<.05;**p<.01;***p<.001 
Note: USS = Unit Social Support Scale 
 
 
 
 
 Cortisol  
Variable β SE t p ΔR2 
USS      
Step 1     .089 
Lifetime Trauma 
Marital Status  
-.243 
-.171 
 
.005 
.019 
 
-2.79 
-1.97 
 
.006 
.052 
 
 
Step 2     .011 
Lifetime Trauma 
Marital Status  
PTSD Severity 
-.213 
-.174 
-.110 
.005 
.019 
.001 
-2.35 
-2.00 
-1.21 
.020 
.048 
.229 
 
Step 3     .000 
Lifetime Trauma 
Marital Status  
PTSD Severity 
USS  
-.211 
-.172 
-.110 
-.015 
.005 
.020 
.001 
.002 
-2.30 
-1.95 
-1.21 
-.167 
.023 
.053 
.231 
.867 
 
Step 4     .001 
Lifetime Trauma 
Marital Status  
PTSD Severity 
USS  
USS*PTSD 
-.216 
-.173 
-.111 
-.012 
.035 
.005 
.020 
.001 
.002 
.000 
-2.32 
-1.96 
-1.22 
-.131 
.390 
.022 
.052 
.226 
.896 
.697 
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Table 6.  
 
Unit Social Support - ACTH 
 ACTH  
Variable β SE t p ΔR2 
USS      
Step 1     .014 
PSS .118 .003 
 
1.31 
 
.193 
 
 
Step 2     .002 
PSS 
PTSD Severity 
.135 
-.050 
.003 
.001 
1.40 
-.515 
.163 
.607 
 
Step 3     .000 
PSS 
PTSD Severity  
USS 
.133 
-.049 
.004 
.003 
.001 
.003 
1.28 
-.505 
.042 
.203 
.614 
.966 
 
Step 4     .002 
PSS 
PTSD Severity  
USS  
USS*PTSD 
.135 
-.053 
.007 
.041 
.003 
.001 
.003 
.000 
1.29 
-.540 
.074 
.444 
.200 
.590 
.941 
.658 
 
*p<.05;**p<.01;***p<.001 
Note: PSS = Post-Deployment Social Support 
          USS = Unit Social Support Scale 
 
 
Trauma load.  Hierarchical regression analyses evaluated the hypothesized influence of 
lifetime trauma load and combat severity on the relation between PTSD symptom severity and 
both basal cortisol and ACTH.  Neither lifetime trauma load nor combat severity significantly 
moderated the relation between PTSD symptom severity and either cortisol or ACTH.  However, 
the main effect of lifetime trauma load (see Table 7) was significantly predictive of baseline 
cortisol in Step 3, β = -.213, t (119) = -2.349, p = .02, accounting for 4.2% incremental variance 
in the model, ∆R2 = .042, ∆F (1, 119) = 5.518, p = .02.  Lifetime trauma load and marital status 
were the only significant predictors of cortisol in the Step 4 for lifetime trauma load, β = -.212, t 
(118) = -2.327, p = .022; β = -.176, t (118) = -2.012, p = .047, respectively.  Lifetime trauma load 
was the sole significant predictor of cortisol in Step 4 for combat severity, β = -.21, t (117) = -
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2.287, p = .024.  No variables significantly predicted ACTH for either lifetime trauma load or 
combat severity.  Please refer to Tables 7-10 for detailed results.   
 
Table 7.  
 
Lifetime Trauma Load - Cortisol 
 Cortisol  
Variable β SE t p ΔR2 
Lifetime Trauma      
Step 1     .030 
Marital Status -.173 
 
.020 
 
-1.94 
 
.000 
 
 
Step 2     .029 
Marital Status 
PTSD Severity 
-.176 
-.169 
.020 
.001 
-1.99 
-1.91 
.049 
.059 
 
Step 3     .042 
Marital Status 
PTSD Severity 
Lifetime Trauma  
-.174 
-.110 
-.213 
.019 
.001 
.005 
-2.00 
-1.21 
-2.35 
.048 
.229 
.020 
 
Step 4     .001 
Marital Status 
PTSD Severity 
Lifetime Trauma 
Lifetime Trauma*PTSD 
-.176 
-.111 
-.212 
.037 
.020 
.001 
.005 
.000 
-2.01 
-1.22 
-2.33 
.420 
.047 
.224 
.022 
.675 
 
*p<.05;**p<.01;***p<.001 
 
Table 8.  
 
Lifetime Trauma Load - ACTH 
 ACTH  
Variable β SE t p ΔR2 
Lifetime trauma      
Step 1     .014 
PSS .118 .003 
 
1.31 
 
.193 
 
 
Step 2     .002 
PSS 
PTSD Severity 
.135 
-.050 
.003 
.001 
1.40 
-.52 
.163 
.607 
 
Step 3     .002 
PSS 
PTSD Severity 
Lifetime Trauma 
.136 
-.036 
-.048 
.003 
.001 
.008 
1.41 
-.365 
-.505 
.162 
.716 
.614 
 
Step 4     .007 
PSS 
PTSD Severity  
Lifetime Trauma 
Lifetime Trauma*PTSD 
.147 
-.044 
-.045 
.084 
.003 
.001 
.008 
.000 
1.51 
-.436 
-.480 
.923 
.133 
.663 
.632 
.358 
 
*p<.05;**p<.01;***p<.001 
Note: PSS= Post-deployment Social Support Scale 
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Table 9.  
 
Combat Severity - Cortisol 
 Cortisol  
Variable β SEB t p ΔR2 
CES      
Step 1     .089 
Lifetime Trauma 
Marital Status 
-.243 
-.171 
.005 
.019 
-2.79 
-1.97 
.006 
.052 
 
Step 2     .011 
Lifetime Trauma  
Marital Status  
PTSD Severity 
-.213 
-.174 
-.110 
.005 
.019 
.001 
-2.35 
-2.00 
-1.21 
.020 
.048 
.229 
 
Step 3     .000 
Lifetime Trauma  
Marital Status  
PTSD Severity 
CES 
-.213 
-.176 
-.102 
-.021 
.005 
.020 
.001 
.005 
-2.35 
-2.00 
-1.05 
-.218 
.021 
.048 
.295 
.828 
 
Step 4     .001 
Lifetime Trauma  
Marital Status  
PTSD Severity 
CES 
CES*PTSD 
-.210 
-.174 
-.112 
-.019 
.028 
.005 
.020 
.001 
.005 
.000 
-2.29 
-1.98 
-1.09 
-.205 
.299 
.024 
.051 
.278 
.838 
.765 
 
*p<.05;**p<.01;***p<.001 
Note: CES=Combat Experiences Scale 
 
Table 10.  
 
Combat Severity - ACTH 
 ACTH  
Variable β SE t p ΔR2 
CES      
Step 1     .014 
PSS .118 .003 
 
1.31 
 
.193 
 
 
Step 2     .002 
PSS 
PTSD Severity 
.135 
-.050 
.003 
.001 
1.40 
-.52 
.163 
.607 
 
Step 3     .005 
PSS 
PTSD Severity  
CES 
.143 
-.027 
-.075 
.003 
.001 
.008 
1.47 
-.264 
-.773 
.144 
.792 
.441 
 
Step 4     .000 
PSS 
PTSD Severity  
CES  
CES*PTSD 
.141 
-.030 
-.074 
.011 
.003 
.001 
.008 
.000 
1.44 
-.285 
-.759 
.116 
.153 
.776 
.449 
.908 
 
*p<.05;**p<.01;***p<.001 
Note: CES = Combat Experiences Scale 
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Sleep.  Hierarchical regression analysis evaluated the hypothesized influence of sleep 
disturbance on the relation between PTSD symptom severity and both basal cortisol and ACTH.  
There was a nominally significant main effect of sleep disturbance on baseline cortisol in Step 3, 
β = -.197, t (115) = -1.902, p = .06, which became significant after including the moderation 
variable into the model in Step 4, β = -.218, t (114) = -2.146, p = .034.  The association between 
PTSD symptom severity and baseline cortisol was significantly moderated by sleep disturbance, β 
= .242, t (113) = 2.541, p = .012, accounting for 4.7% incremental variance in the model, ∆R2 = 
.047, ∆F (1, 114) = 6.455, p = .012.  Thus, sleep disturbance, lifetime trauma load, and the 
interaction between PTSD symptom severity and sleep disturbance significantly predicted 
baseline cortisol in the Step 4.  Interestingly, as illustrated in Figure 2, individuals with low sleep 
disturbance and low PTSD symptom severity had high levels of basal cortisol compared to 
individuals with medium and high sleep disturbances.  Conversely, individuals with high sleep 
disturbance and high PTSD symptom severity had high levels of basal cortisol compared to 
individuals with medium and low sleep disturbance, demonstrating a crossover interaction.  Thus, 
the direction of the relationship between PTSD symptom severity and cortisol changes depending 
on whether an individual has low or high levels of sleep disturbance.  As with all previous 
examined moderators, no variables significantly predicted ACTH.  Please refer to Tables 11 & 12 
for detailed results.   
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Note: Moderation analyses included all participants for whom a CAPS score was 
available.  A subset of participants in the NTC group (n=12) were administered the CAPS 
for assurance of group assignment. 
 
Figure 2. Moderating Effect of Sleep Disturbance on Relation between PTSD Symptom Severity 
and Basal Cortisol 
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Table 11.  
 
Sleep - Cortisol 
 Cortisol  
Variable β SE t p ΔR2 
PSQI      
Step 1     .082 
Lifetime Trauma 
Marital Status 
-.238 
-.163 
 
.005 
.020 
 
-2.69 
-1.84 
 
.008 
.069 
 
 
Step 2     .011 
Lifetime Trauma 
Marital Status  
PTSD Severity 
-.208 
-.166 
-.108 
.005 
.020 
.001 
-2.26 
-1.88 
-1.17 
.026 
.063 
.245 
 
Step 3     .028 
Lifetime Trauma 
Marital Status  
PTSD Severity 
PSQI 
-.213 
-.163 
-.001 
-.197 
.005 
.020 
.001 
.006 
-2.34 
-1.86 
-.010 
-1.90 
.021 
.066 
.992 
.060 
 
Step 4     .047 
Lifetime Trauma 
Marital Status  
PTSD Severity 
PSQI  
PSQI *PTSD 
-.179 
-.117 
-.087 
-.218 
.242 
.005 
.020 
.001 
.006 
.000 
-1.98 
-1.34 
-.796 
-2.15 
2.54 
.050 
.183 
.428 
.034 
.012 
 
*p<.05;**p<.01;***p<.001 
Note: PSQI= Pittsburg Sleep Quality Index  
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Table 12.  
 
Sleep - ACTH 
 ACTH  
Variable β SE t p ΔR2 
PSQI      
Step 1     .016 
PSS .124 .003 
 
1.36 
 
.175 
 
 
Step 2     .002 
PSS 
PTSD Severity 
.141 
-.048 
.003 
.001 
1.44 
-.49 
.152 
.627 
 
Step 3     .002 
PSS 
PTSD Severity  
PSQI 
.142 
-.074 
.049 
.003 
002 
.009 
1.45 
-.649 
.453 
 
.150 
.518 
.652 
 
Step 4     .000 
PSS 
PTSD Severity  
PSQI 
PSQI*PTSD 
.142 
-.068 
.050 
-.018 
.003 
.002 
.009 
.000 
1.44 
-.573 
.461 
-.182 
.151 
.568 
.646 
.856 
 
*p<.05;**p<.01;***p<.001 
Note: PSS= Post-deployment Social Support Scale 
PSQI= Pittsburg Sleep Quality Index 
 
 
 Given the significant moderating effect of sleep disturbance on the relation between PTSD 
symptom severity and cortisol, further exploratory analyses were conducted to determine whether 
this moderating effect held uniform across the DSM-IV PTSD symptom clusters (i.e., re-
experiencing, avoidance, arousal), or whether the effect was driven by certain symptom clusters.  
Therefore, three additional exploratory hierarchical regression analyses were conducted, one with 
each symptom cluster as the independent variable.  First, the association between symptom 
severity in the re-experiencing cluster and baseline cortisol was significantly moderated by sleep 
disturbance, β = .191, t (116) = 2.143, p = .034, accounting for 3.3% incremental variance in the 
model, ∆R2 = .033, ∆F (1, 116) = 4.594, p = .034.  Second, the association between symptom 
severity in the avoidance cluster and baseline cortisol was significantly moderated by sleep 
disturbance, β = .184, t (117) = 2.114, p = .037, accounting for 3.2% incremental variance in the 
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model, ∆R2 = .032, ∆F (1, 117) = 4.468, p = .037.  Third, the association between symptom 
severity in the arousal cluster and baseline cortisol was significantly moderated by sleep 
disturbance, β = .192, t (116) = 2.175, p = .032, accounting for 3.4% incremental variance in the 
model, ∆R2 = .034, ∆F (1, 116) = 4.732, p = .032.  Thus, the moderating effect of sleep 
disturbance on the relation between PTSD and cortisol was demonstrated to be significant across 
the PTSD symptom clusters.  Please refer to Tables 13-15 for detailed results. 
 
Table 13.  
 
Re-experiencing  
 Cortisol  
Variable β SE t p ΔR2 
PSQI      
Step 1     .084 
Lifetime Trauma 
Marital Status 
-.242 
-.167 
 
.005 
.020 
 
-2.75 
-1.90 
 
.007 
.060 
 
 
Step 2     .004 
Lifetime Trauma 
Marital Status  
Re-experiencing  
-.230 
-.171 
-.067 
.005 
.020 
.039 
-2.57 
-1.94 
-.752 
.011 
.055 
.453 
 
Step 3     .034 
Lifetime Trauma 
Marital Status  
Re-experiencing 
PSQI 
-.223 
-.162 
.007 
-.200 
.005 
.019 
.042 
.005 
-2.53 
-1.87 
.072 
-2.14 
.013 
.065 
.942 
.035 
 
Step 4     .033 
Lifetime Trauma 
Marital Status  
Re-experiencing 
PSQI  
PSQI *Re-experiencing 
-.219 
-.143 
-.009 
-.242 
.191 
.005 
.019 
.041 
.005 
.010 
-2.52 
-1.66 
-.091 
-2.57 
2.14 
.013 
.099 
.928 
.011 
.034 
 
*p<.05;**p<.01;***p<.001 
Note: PSQI= Pittsburg Sleep Quality Index  
 
 
 
 
 
 
 
 
   
 		
		 69	
Table 14.  
 
Avoidance 
 Cortisol  
Variable β SE t p ΔR2 
PSQI      
Step 1     .086 
Lifetime Trauma 
Marital Status 
-.246 
-.168 
 
.005 
.020 
 
-2.81 
-1.92 
 
.006 
.057 
 
 
Step 2     .016 
Lifetime Trauma 
Marital Status  
Avoidance  
-.207 
-.169 
-.134 
.005 
.019 
.034 
-2.29 
-1.95 
-1.48 
.024 
.054 
.143 
 
Step 3     .024 
Lifetime Trauma 
Marital Status  
Avoidance  
PSQI 
-.205 
-.167 
-.061 
-.173 
.005 
.019 
.037 
.006 
-2.28 
-1.94 
-.626 
-1.82 
.024 
.055 
.533 
.071 
 
Step 4     .032 
LifetimeTrauma 
Marital Status  
Avoidance 
PSQI  
PSQI * Avoidance 
-.189 
-.141 
-.058 
-.204 
.184 
.005 
.019 
.037 
.006 
.010 
-2.13 
-1.65 
-.602 
-2.16 
2.11 
.036 
.102 
.548 
.033 
.037 
 
*p<.05;**p<.01;***p<.001 
Note: PSQI= Pittsburg Sleep Quality Index  
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Table 15.  
 
Hyperarousal 
 Cortisol  
Variable β SE t p ΔR2 
PSQI      
Step 1     .083 
Lifetime Trauma 
Marital Status 
-.244 
-.165 
 
.005 
.020 
 
-2.77 
-1.87 
 
.006 
.063 
 
 
Step 2     .005 
Lifetime Trauma 
Marital Status  
Hyperarousal 
-.221 
-.162 
-.077 
.005 
.020 
.002 
-2.40 
-1.84 
-.837 
.018 
.068 
.404 
 
Step 3     .033 
LifetimeTrauma 
Marital Status  
Hyperarousal  
PSQI 
-.226 
-.165 
.037 
-.215 
.005 
.019 
.003 
.006 
-2.49 
-1.91 
.353 
-2.11 
.014 
.059 
.725 
.037 
 
Step 4     .034 
Lifetime Trauma 
Marital Status  
Hyperarousal 
PSQI  
PSQI * Hyperarousal 
-.217 
-.121 
.030 
-.235 
.192 
.005 
.020 
.003 
.006 
.001 
-2.42 
-1.38 
.284 
-2.33 
2.18 
.017 
.170 
.777 
.021 
.032 
 
*p<.05;**p<.01;***p<.001 
Note: PSQI= Pittsburg Sleep Quality Index  
 
 
 
 
Discussion 
 
 The primary aim of this study was to compare baseline neuroendocrine levels by trauma 
group among a sample of OIF/OEF/OND veterans.  Specifically, this study sought to examine 
basal cortisol and ACTH to test whether levels differed significantly by individuals in the NTC, 
TE, or PTSD groups.  To further understand the relationship between trauma group and these 
biomarkers, an exploratory aim was to examine potential moderators of the relationship between 
PTSD symptom severity and basal neuroendocrine levels.  
 
Trauma Group Differences on Cortisol and ACTH 
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The primary aim of the present study sought to determine whether basal cortisol and 
ACTH differed according to trauma group. The ANOVA examining group differences in cortisol 
was marginally significant (p=.054), suggesting that mean basal cortisol levels likely differ 
according to trauma group.  Post-hoc tests revealed that mean basal cortisol levels differed 
significantly between NTC and PTSD groups, with the NTC group having significantly higher 
levels of cortisol than the PTSD group.  Mean scores of baseline cortisol in the TE group did not 
differ from the NTC or PTSD groups, supporting the notion that aberrant patterns in physiology 
are unique to the psychopathological effects of trauma as opposed to exposure to trauma alone.  
Notably, this is one of the first studies to examine cortisol and ACTH in the 
OEF/OIF/OND population, which tend to be younger in age compared to veterans of other 
conflicts.  Much of the extant research examining basal effects of cortisol and ACTH have been 
conducted in civilian (e.g., Newport et al., 2004) or older military populations (e.g., Gulf War, 
Vietnam, etc.; Golier et al., 2007; Liberzon et al., 1999).  Although this is one of the first studies 
to examine the neuroendocrine effects of combat exposure from the OEF/OIF/OND conflicts, 
these findings are consistent with much of the extant literature, which has demonstrated lower 
basal cortisol levels in PTSD patients compared to nonclinical samples (De Kloet et al., 2007; 
Klaassens et al., 2012; Neylan et al., 2005; Rohleder et al., 2004; Wessa et al., 2006; Yehuda et 
al., 2005; Yehuda et al., 2004; Yehuda et al., 2002; Yehuda, Southwick, & Krystal, 1993).  
Notably, however, unlike the present findings, several studies have demonstrated lower basal 
cortisol in both the PTSD and TE groups compared to the NTC group (De Kloet et al., 2007; 
Horn et al., 2014; Klaassens et al., 2012).  However, consistent with findings from the present 
study, these studies have also failed to find any statistical differences between PTSD and TE 
basal cortisol levels.   
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As suggested by Morris et al. (2012), differential categorization of control groups (i.e., 
combined TE and NTC vs. NTC only) could contribute to the inconsistency of the literature, such 
that combining two groups with varied experiences (TE and NTC) into one conditional “non-
clinical” group could lead to misrepresentation of control groups.  Furthermore, differential 
findings could likely reflect differences in measurement methodology.  In their systematic review 
and meta-analysis, Meewisse and colleagues (2007) pooled across studies using different types of 
measurement (i.e., urine, saliva, plasma, or serum) to conduct subgroup analyses.  These 
subgroup analyses demonstrated that studies assessing cortisol via plasma or serum showed 
significantly lower levels in people with PTSD compared to NTC group, but did not differ 
between PTSD and TE individuals.  Indeed, these and the present findings may suggest that 
differences in cortisol levels relate to being exposed to trauma general, rather than to the 
acquisition of PTSD. 
In addition to inconsistent categorization of control groups in the extant literature, 
psychiatric comorbidity is an important consideration when discussing the mixed findings within 
the literature, with some studies excluding individuals with comorbid psychiatric disorders and 
others not.  A meta-analysis examining basal neuroendocrine levels among individuals with 
comorbid PTSD and MDD found that daily cortisol output was significantly lower for the PTSD 
and comorbid PTSD and MDD groups, compared to the NTCs and, similar to the present 
findings, TE and NTC groups did not differ significantly (Morris et al., 2012).  Similarly Newport 
and colleagues (2004) also considered comorbidity in their study investigating women with child 
abuse histories and diagnoses of either PTSD, MDD, or comorbid PTSD and MDD and found 
that, compared to healthy controls individuals with early childhood abuse and PTSD had 
significantly lower baseline plasma cortisol levels.  Unlike the aforementioned studies, the 
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present study excluded individuals with psychiatric comorbidities.  However, findings of lower 
basal cortisol among individuals with PTSD were consistent across studies that included co-
occurring disorders (Morris et al., 2012; Newport et al., 2004), suggesting comorbidity may not 
influence the direction of basal cortisol among individuals with PTSD.   
Although the present findings are consistent with the majority of studies in the extant 
literature which have demonstrated overall lower baseline cortisol levels among PTSD 
individuals (e.g., De Kloet et al., 2007; Klaassens et al., 2012; Neylan et al., 2005; Rohleder et al., 
2004; Wessa et al., 2006; Yehuda et al., 2005; Yehuda et al., 2004; Yehuda et al., 2002; Yehuda, 
Southwick, & Krystal, 1993) and frequently TE individuals as well (De Kloet et al., 2007; Horn 
et al., 2014; Klaassens et al., 2012) , they are inconsistent with a number of studies that have 
reported higher basal cortisol levels in patients with PTSD (Baker et al., 2005; Golier et al., 2012; 
Inslicht et al., 2006; Klaassens et al., 2012; Liberzon et al., 1999; Lindley et al., 2004; Young & 
Breslau, 2004).  There have been numerous postulates in the literature as to why findings are 
mixed for directionality in the cortisol PTSD literature. Once more, it is likely that variations in 
assessment methodology largely account for the discrepancies in the literature surrounding basal 
neuroendocrine activity.  Although no patterns emerge between methodologies used in studies 
finding lower basal cortisol among individuals PTSD versus studies finding higher basal cortisol 
among individuals with PTSD, lack of conformity between and even within studies may account 
for the discrepant findings.  For instance, Baker et al. (2005) compared CSF, plasma, and urinary 
cortisol measurements in individuals with combat-related PTSD to healthy controls.  No group 
differences were detected in the plasma or urinary free cortisol.  However, mean CSF cortisol 
concentrations were significantly higher in the PTSD positive individuals compared to the healthy 
controls.  The authors explain this incongruence of findings by stating that CSF cortisol more 
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accurately illustrates brain glucocorticoid levels.  Indeed, it is noteworthy to reiterate that various 
assessment mediums (e.g., blood, saliva, urine, etc.) reflect various concentrations of cortisol 
(Meewisse et al., 2007).  For example, whereas salivary cortisol consists of completely free (i.e., 
biologically active, unbound) fraction, less than 10% of cortisol in plasma is free (Le Roux et al., 
2002).  The majority is bound to cortisol-binding globulin (CBG) or other proteins and is 
biologically inactive.  Because the majority of cortisol in serum is bound to proteins, changes in 
binding proteins can alter measured serum/plasma cortisol concentrations without influencing 
free concentrations (Hamrahian, Oseni, & Arafah, 2004).  Several conditions (e.g., pregnancy, 
hypothyroidism, obesity) and oral contraceptive use are known to influence CBG levels 
(Westermann, Demir, & Herbst, 2004).  Although pregnancy and obesity are exclusionary criteria 
in the parent study, hypothyroidism and use of oral contraceptives are not screened out and may 
serve to influence the present results.  Furthermore, results of other published studies may be 
affected by the failure to control for these factors.    
The present findings, indicating lower levels of basal cortisol among individuals with 
PTSD compared to NTCs, are in contrast to the few studies that have failed to find any significant 
differences in basal cortisol between PTSD, NTC, and TE groups (Hockings et al., 1993; 
Klaassens et al., 2012; Lindley et al., 2004; Meewisse et al., 2007; Miller et al., 2007; Savic et al., 
2012).  Interestingly, overall results from several meta-analyses indicated no significant 
differences in basal cortisol levels between PTSD and control groups.  (Klaassens et al., 2012; 
Meewisse et al., 2007; Miller et al., 2007).  However, subgroup analyses within these studies 
typically did reveal significant differences, depending on considered variables.  Lack of 
standardization across the different studies examined in these meta-analyses likely accounts for 
the null findings, such that lack of uniformity across assessment mediums and methodology likely 
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results in non-comparable basal cortisol levels between studies.  Regardless, results of the 
ANOVA (albeit nominally significant) and post-hoc tests were in line with the proposed 
hypothesis that mean basal cortisol levels would be significantly lower among individuals in the 
PTSD group.   
No significant group differences were found for ACTH.  Lack of significant findings for 
group differences on basal ACTH in the present study is consistent with the much of the current 
literature, which has failed to find significant differences in baseline ACTH between PTSD, TE, 
and NTC conditions (Baker et al., 2005; Golier et al., 2012; Liberzon et al., 1999; Savic et al., 
2012).  However, these findings are contradictory with results from two studies which 
demonstrated higher basal ACTH among individuals with PTSD when compared to their TE and 
NTC counterparts (de Kloet et al., 2012; Golier et al., 2007).  Notably, however, the study by 
Golier and colleagues (2007) demonstrated significantly higher basal levels of ACTH in the 
PTSD group compared to the TE group only.  Furthermore, ACTH levels were also significantly 
higher in the NTC group compared to the TE group, suggesting the effect was perhaps due to 
extraneous factors.   
Regardless, lack of significant findings for group differences on basal ACTH in the 
present study could be accounted for by a number of explanations.  First, fewer studies have 
examined ACTH than cortisol, both at baseline and in response to a stressor.  To our knowledge, 
only six studies have examined basal ACTH (Baker et al., 2005; de Kloet et al., 2012; Golier et 
al., 2012; Golier et al., 2007; Liberzon et al., 1999; Savic et al., 2012).  As previously discussed, 
this gap in the literature could be due to the fact that that ACTH is a serum-based biomarker.  
Because typically fewer studies use blood serum-based assessments, the lack of ACTH 
assessments in the literature could be due largely to logistical limitations.  However, it is also 
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possible that far fewer findings on basal ACTH have been published because an effect for ACTH 
is infrequently demonstrated.  Because null findings are less likely to be accepted for publication, 
this shortage of studies reporting on basal ACTH could be attributed to a consistent lack of effect 
found for ACTH. However, it is possible that ACTH plays a more critical role in stress reactivity 
rather than at resting state.      
To that end, most of extant literature has examined ACTH as a baseline by which to 
compare reactivity.  Using a baseline assessment as a comparison for a reactivity assessment does 
not necessarily require the stringent standardization that assessing baseline levels alone might.  
For instance, variations in basal assessments (e.g., time, place, medium, etc.) are less detrimental 
to the study design when the basal assessment is serving only as a comparison group for 
reactivity.  Variations in basal assessments are more likely to be confounding, however, when the 
primary goal of the assessment is to examine basal functioning.  Therefore, because the majority 
of studies examining basal ACTH have done so to compare ACTH at baseline to ACTH at 
reactivity, it is possible, in fact evident, that less standardization between studies took place.  This 
same limitation can also be applied to the aforementioned cortisol studies.   
 
Summary of Aim One 
Group differences in cortisol were marginally significant, with post-hoc analyses 
revealing that the NTC group had significantly higher levels of cortisol than the PTSD group, 
supporting the hypothesis that cortisol would be lower in the PTSD group.  Mean scores of 
baseline cortisol in the TE group did not differ from the NTC or PTSD groups.  These findings 
are consistent with the majority of the extant literature, which has demonstrated lower basal 
cortisol levels in PTSD patients compared to nonclinical samples.  No significant group 
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differences were found for ACTH.  Lack of significant findings for group differences on basal 
ACTH in the present study is consistent with the majority of the current literature, which has 
failed to find significant differences in baseline ACTH between PTSD, TE, and NTC conditions.  
Notably, this is one of the first studies to examine cortisol and ACTH in the OEF/OIF/OND 
population.   
 
Moderation Analyses 
An exploratory aim was to examine potential moderators of the relationship between 
PTSD symptom severity and basal neuroendocrine levels.  Sleep disturbance was the only 
significant moderator of the relation between PTSD symptom severity and basal cortisol.  
Individuals with low sleep disturbance and low PTSD symptom severity had high levels of basal 
cortisol compared to individuals with medium and high sleep disturbances.  Interestingly, 
however, individuals with high sleep disturbance and high PTSD symptom severity also had high 
levels of basal cortisol compared to individuals with medium and low sleep disturbance, 
indicating a crossover interaction in which the direction of the relationship changes depending on 
whether an individual has low or high levels of sleep disturbance.  This finding suggests that 
greater sleep disturbance may have more of an effect on basal cortisol in individuals with low 
levels of PTSD symptom severity, whereas the effects of sleep disturbance may not be as 
profound in individuals with medium or high PTSD symptomatology.  In other words, PTSD 
severity likely has more of an effect on basal cortisol than does sleep disturbance when present at 
high levels in conjunction.  This finding could suggest that the neuroendocrine system in 
individuals with high PTSD symptom severity is more reactive to the influences of sleep 
disturbance than individuals with lower levels of sleep disturbance.  Research suggests that basal 
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cortisol levels among individuals with PTSD are lower in late night and early morning hours, and 
remain lower throughout the night, compared to healthy controls (Yehuda, 2002).  This lack of 
diurnal modulation could perhaps explain why, unlike individuals with PTSD and low sleep 
disturbance (suggesting an adequately modulating cortisol pattern), individuals with PTSD and 
high sleep disturbance display higher basal cortisol.  
To determine if the moderation effect of sleep disturbance was driven by any of the PTSD 
symptom clusters in particular, follow-up analyses were conducted. These exploratory analyses 
indicated that the moderating effect of sleep persisted across PTSD symptom clusters, 
significantly influencing the relationship between re-experiencing symptoms, avoidance 
symptoms, and arousal symptoms and basal cortisol.  These findings suggest that sleep plays an 
influential role on basal cortisol levels across the three different PTSD symptom clusters, 
indicating that no one cluster was accounting for the significance of the moderator in the initial 
sleep moderation analysis.  
One possible explanation as to why sleep disturbance was the only significant moderator 
of all of the other hypothesized moderators is the proximal nature of its assessment.  Whereas the 
other examined moderators are more distal in nature (e.g., social support, lifetime and combat 
trauma load), sleep is a more proximal variable.  For instance, whereas the social support and 
trauma load measures assess events that may have occurred years prior the assessment (i.e., unit 
social support, social support following deployment, trauma during combat, lifetime trauma load), 
the sleep measure used in the present study assessed past month sleep disturbances.  
In addition to sleep being the only significant moderator, lifetime trauma load was the 
only variable of interest that demonstrated a significant main effect on basal cortisol. Greater 
lifetime trauma load was negatively associated with basal cortisol, such that individuals with 
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higher lifetime trauma loads had lower basal cortisol.  These findings are consistent with prior 
research, which demonstrates that basal cortisol is lower among individuals with current PTSD 
who report a history of childhood abuse (Newport et al., 2004).  Although some research has been 
done examining baseline cortisol and ACTH among survivors of childhood abuse (Morris et al., 
2012; Savic et al., 2012), studies controlling for the effects of lifetime trauma load in analyses 
examining basal neuroendocrine indices are scarce (Golier et al., 2012).   
The present findings may suggest a cumulative effect of lifetime trauma on the HPA-axis 
system, wherein chronic stress or trauma leads to the perpetuation or failure of the stress system 
activation.  This disruption to the stress system activation prompts the development of an 
allostatic load, inevitably making the neuroendocrine system more vulnerable to stress (De Kloet 
et al., 2005).  Animal studies have suggested that sustained exposure to trauma leads to elevated 
cortisol signaling capacity, which in turn results in lower levels of cortisol efficiently suppressing 
HPA axis functioning (De Kloet et al., 2005).  This relationship between trauma load and 
suppressed cortisol output is further supported by animal models, which have found reinstating 
appropriate HPA signaling to be an effective treatment approach for PTSD (Cohen et al., 2006; 
De Kloet et al., 2005).  Based on the rationale that endogenous cortisol provides an inadequate 
signal to contain the stress reactions of PTSD patients, pilot studies have shown that cortisol 
administration ameliorated PTSD symptoms (Aerni et al., 2014; Schelling et al., 2004).   
 Integrating these findings in the context of the present study’s main hypotheses (i.e., 
PTSD will result in lower basal cortisol) could suggest that individuals with higher lifetime 
trauma load may be more likely to have PTSD, which in turn is affecting the HPA-axis.  
Conversely, it could be that greater exposure to trauma affects the HPA-axis, which in turn, gives 
rise to PTSD.  This positive association between cumulative effects of trauma and PTSD 
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likelihood is vastly reported in the literature, which suggests that greater exposure to multiple 
traumatic events is predictive of greater PTSD symptomatology (Breslau, 2009; Cloitre et al., 
2009; Messman-Moore et al., 2000).  Indeed, investigation into the direction and causality of the 
effects of trauma exposure on HPA-axis functioning and development of PTSD is a promising 
future direction, such that risk factors may be identified and thus targeted through early 
intervention.    
Although lifetime trauma load was the only significant main effect predicting basal 
cortisol across all five cortisol models, the main effect of sleep did become significant when the 
interaction term for sleep and PTSD symptom severity was added into the final step of the sleep 
model for cortisol.  Additionally, several control variables were significantly predictive of basal 
cortisol in the final step of several of the models.  For instance, lifetime trauma load significantly 
predicted baseline cortisol across the cortisol models.  Surprisingly, given the relation between 
trauma load and PTSD symptom severity (Dohrenwend et al., 2006; McNally, 2006), lifetime 
trauma load has been infrequently controlled for in studies examining basal cortisol (e.g., Golier 
et al., 2012), and thus, it is difficult to say whether this finding is consistent with previous 
research.  However, these findings, coupled with existing evidence for the inverse relationship 
between cumulative effects of early trauma and basal cortisol e.g., (Newport et al., 2004), 
highlight the need for future studies to account for lifetime trauma load in analyses when 
examining the effects of certain factors on basal cortisol. Also, marital status was significantly 
negatively associated with basal cortisol in the final step of the model examining the moderating 
effects of lifetime trauma load.   
Notably, no variables (control or otherwise) significantly predicted basal ACTH in any of 
the five ACTH models.  The same explanations for the lack of effect seen in the ANOVA 
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examining group differences in basal ACTH may be relevant in the explanation of the null 
moderation results.  The lack of variables significantly predicting basal ACTH could be simply 
due to the fact that basal ACTH is not as indicative a biomarker of trauma and trauma-related 
psychopathology (i.e., PTSD) as its neuroendocrine counterpart, cortisol.  It could be that ACTH 
is not as affected by trauma more generally, or possibly that trauma-related effects on ACTH are 
more adequately demonstrated in reactivity, rather than basal, states.    
 
Summary of Aim Two 
Sleep disturbance was the only significant moderator of the relation between PTSD 
symptom severity and basal cortisol, such that the effect of greater sleep disturbance on basal 
cortisol was more profound in individuals with low levels of PTSD symptom severity, but not in 
individuals with medium or high levels of PTSD symptom severity.  That is to say there was a 
demonstrated greater effect of PTSD on basal cortisol than sleep disturbance when both sleep and 
PTSD symptoms were high.  The moderating effect of sleep remained consistent in analyses 
across PTSD symptom clusters, suggesting no one cluster was accounting for the significance of 
the moderator in the initial sleep moderation analysis.  Furthermore, lifetime trauma load was 
persistently predictive of basal cortisol.  Across all five cortisol models, lifetime trauma load was 
negatively associated with basal cortisol, such that individuals with higher lifetime trauma loads 
had lower basal cortisol.  No predictive or moderating effects were demonstrated for ACTH. 
 
Limitations 
Limitations of the present study include a modest sample size and unequal sample sizes 
between the trauma groups.  Because tests of ANOVA assume equal variance across groups and 
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are robust against small deviations from heterogeneity of variance (i.e., homoscedasticity), the 
unequal sample sizes between groups proves a limitation.  However, a hypothesis test was 
performed to validate the assumption, (i.e., Levene's Test) and showed that the assumption of 
homoegenity of variance was met for each group for both cortisol and ACTH.  Notably, these 
tests are not powerful to detect small deviations; however, they are able to detect larger 
deviations.  Additionally, deviation from heterogeneity of variance was checked by inspecting 
residual plots, which showed that all group variances were near to equal.  Moreover, despite the 
fact that the ANOVA examining group differences on cortisol demonstrated a nominally 
significant effect, the present study is limited in that post-hoc tests were conducted in the absence 
of a true significant finding (p<.05).  Although results of the post-hoc tests demonstrated 
significant differences in basal cortisol between the NTC and PTSD groups, post-hoc analyses are 
typically not conducted in the absence of a significant ANOVA result  and thus should be 
interpreted with caution. 
Additionally, the present study was largely underpowered to examine gender differences, 
as the vast majority of the total study sample was composed of males (89.9%).  Considering 
disparate rates of PTSD among men and women (Breslau et al., 1998; Kessler et al., 1995; 
Kilpatrick et al., 2003), as well as the varied likelihood of experiencing certain types of combat 
trauma according to gender (Street et al., 2013; Vogt et al., 2011; Vogt et al., 2005), future studies 
should account for gender differences when investigating the potential influence of combat 
trauma exposure on neuroendocrine activity. 
Furthermore, although the aims of the study were to compare basal cortisol and ACTH 
between trauma groups, the samples assessed were likely not the purest baseline measure of these 
neuroendocrine markers.  For instance, although participants were given approximately an hour to 
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acclimate to the testing environment and the insertion of the indwelling catheter, it is possible that 
the anticipation of the upcoming blood draws and/or lab procedures could have resulted in 
manipulated “basal” states.   However, this possibility is small, considering the information 
provided to participants during the consenting process is worded in an accurate, yet non-
threatening way:  
“On the day of your appointment, you will meet a member of the research team at the 
VIPBG where you are today and they will walk with you to the CRSU at 4:00 pm…If 
urine tests are clean, you will be fitted with a blood pressure cuff and a catheter in your 
arm through which small samples of blood will be drawn. No more than 75 mls (about 5 
tablespoons) of blood will be taken from your arm over the course of the testing session. 
Your blood pressure, heart rate, and breath alcohol levels will also be assessed several 
times during the testing session.  The time spent in the CRSU will be used to further 
collect data regarding personality and alcohol preferences. For example, you will be asked 
to complete more questionnaires; you may be asked to participate in a mock job interview 
(to assess extraversion, which is a personality trait), and to complete a mental math test (to 
assess short term memory); you may also be asked to stand on a balance board (to assess 
you balance).  Your activities during the testing will be recorded on videotape for later 
scoring.  The videotape is erased within one month of your testing session…” 
 
 
 Indeed, even the description of the stress paradigm is described in a manner that that 
informs the participant of their potential to participate in the task, while at the same time using 
non-threatening language that likely would not induce enough anticipatory stress to affect the 
participants’ basal neuroendocrine activity.  Moreover, given that the informed consent is 
administered during the initial office visit, it is typically administered approximately a week (or 
more) prior to the laboratory visit, making anticipatory stress less acute.   
 Another potential limitation of the study involves the diurnal fluctuation of cortisol and 
ACTH in basal assessment.  However, the schedule for the lab procedures was designed to 
accommodate this fluctuation, assessing for both neuroendocrine markers at a standardized 
timepoint in which cortisol and ACTH have been shown to modulate over the course of their 24 
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hour pattern by metabolic inputs relating to blood glucose levels, around 5PM (See Figure 3; 
Lovallo, 2006; Van Cauter et al., 1992).  Moreover, assessing basal cortisol and ACTH in a 
highly standardized manner, wherein baseline samples were obtained at the same time for each 
participant, will likely reduce the likelihood of diurnal variation.  To that end, assessing basal 
cortisol and ACTH via serum likely produces a more temporally accurate baseline measure, 
unlike the use of other, more distal mediums through which cortisol can be assessed (e.g., urinary 
cortisol; Handwerger, 2009).   
 
 
Figure 3. Standardized assessment of cortisol. Adapted from “Cortisol secretion patterns in 
addiction and addiction risk.,” by W.R. Lovallo, 2006, International Journal of 
Psychophysiology, 59(3), p. 195-202.  
 
Implications 
   
 		
		 85	
The findings from the present study indicate an effect of PTSD on basal neuroendocrine 
functioning, particularly on cortisol.  It is noteworthy, however, that although differences in basal 
cortisol were marginally significant in the ANOVA, and there were significant differences 
revealed in post-hoc comparisons, the present findings do not necessarily support the use of 
cortisol as a diagnostic biomarker for PTSD.  A biomarker is defined as a unique identifier of a 
condition that can be measured in a laboratory that occurs as a result of the disease process (Katz, 
2004).  A more inclusive definition suggests that a biomarker is defined by any reliable measure 
associated with the presence and severity of a specific disease state (Naylor, 2003).  Working 
from these definitions, Yehuda and colleagues (2013) emphasize the reliable standards by which 
a biomarker must be determined.  They state that, in order for a biomarker to be effective 
clinically or empirically, it must perform consistently across laboratories and population samples, 
with established reference ranges for normative populations against which it can be compared.  
Because cortisol has not been demonstrated to perform consistently across—and occasionally 
within—samples, and because there are no established reference ranges by which abnormal 
cortisol levels can be compared, extensive and more sophisticated investigation of cortisol in 
relation to trauma and trauma-related phenotypes is warranted before it may be implicated as a 
biomarker.  To that end, replications in larger and varied samples are necessary before inferences 
can be made regarding the predictive utility of cortisol as a biomarker for PTSD.   
Although inferences cannot be made from these findings to implicate cortisol as a 
diagnostic biomarker, research in this area may still yield important clues into the etiology of 
PTSD. The findings of the present study fit with current theories of PTSD relating to aberrant 
stress responses.  Furthermore, applying this area of research to target potentially modifiable risk 
factors (e.g., sleep) that cushion the effects of environmental and biologic vulnerability to 
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negative mental health outcomes following trauma will have significant clinical implications 
(Amstadter et al., 2009).  To that end, the finding that sleep disturbance significantly moderated 
the relation between PTSD symptom severity and basal cortisol, such that sleep disturbance had a 
greater effect on cortisol among individuals with low PTSD symptom severity than among 
individuals with medium or high PTSD symptom severity, suggests that perhaps sleep should be 
a primary focus of treatment only after PTSD symptom severity has been managed.  For instance, 
therapeutic attempts to target sleep among individuals with high levels of PTSD symptomatology 
may prove less effective until PTSD symptom severity is decreased.   
The demonstrated effect of lifetime trauma load on basal cortisol, evidenced consistently 
across all cortisol models, also has important clinical and empirical relevance.  This relationship 
between cumulative trauma and negative mental health outcomes later in life holds meaningful 
developmental and clinical implications, suggesting that early experiences have lasting effects 
and may even serve as latent factors which predispose an individual to psychopathological 
development following an adverse event later in life (Messman-Moore & Long, 2000; Wolfe & 
Kimerling, 1997).  Effects of cumulative trauma on development of PTSD may be of particular 
relevance among female veterans, seeing as rates of military sexual trauma (MST) are 
devastatingly high (approximately 20-40%; Surís & Lind, 2008).  Thus, these findings could be 
applied to inform veteran- and MST-based treatment programs, calling for thorough assessment 
of pre-deployment history.  The mechanisms underlying the relationship between early trauma 
and PTSD following trauma later in life require more understanding; this research would most 
likely benefit from an interdisciplinary approach, that accounts for multiple variables, such as 
psychosocial, cultural, biological and epigenetic factors.  Although further interdisciplinary 
research is needed to elucidate underlying mechanisms of PTSD etiology, these findings offer 
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invaluable insight into the complex and interactive nature of differential responses to trauma, as 
well as underscore the importance of considering the influential and lasting effects that early 
childhood events have on later functioning, as triggered by the experience of a traumatic event in 
adulthood. 
  
Future Directions 
Findings from the present study may inform future investigations into neuroendocrine 
associations with trauma and trauma-related psychopathology.  For instance, the sample used in 
the present study was from a larger parent study, which is currently mid-way through data 
collection.  Because results of the present study were only marginally significant, with relative 
small effect sizes and large standard errors, re-running the analyses in the larger final sample may 
increase power, thus increasing the precision by which the effects are estimated (i.e., decreasing 
standard error).  Another interesting future direction with which to expand these findings would 
be to examine cortisol and ACTH reactivity within the sample.  Investigating trauma group 
differences on, as well as potential moderators influencing, neuroendocrine reactivity would 
likely provide a more comprehensive picture of the hypothesized effects of PTSD on the HPA-
axis negative feedback loop.  Furthermore, in light of the null effects of ACTH in present 
findings, follow-up analyses would allow for the potential differentiating effect of ACTH 
reactivity to be demonstrated.  In other words, investigating the effect of trauma group on ACTH 
reactivity, as well as potential moderators of the relation between PTSD symptom severity and 
ACTH reactivity, would help distinguish whether no effects were seen for basal ACTH due to a 
lack of influence of PTSD on ACTH, or whether PTSD influences ACTH reactivity only. 
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Furthermore, seeing as the present study was restricted to combat trauma only, 
examination of the effect of other types of trauma on neuroendocrine activity may be a useful 
future direction.  The differential effects of various trauma types on PTSD (e.g., interpersonal vs. 
accidental; Breslau et al., 1991; Kessler & Üstün, 2004) may also be seen at a biological level.  
Similarly, examination of other potential moderators of the relationship between PTSD and basal 
cortisol and ACTH is warranted, particularly because only one of the examined variables 
significantly moderated the relationship in the present study.   
In addition to replication of analyses within larger and varied samples, clinical 
considerations provide several promising future directions to extend this research.  For instance, 
because sleep disturbance significantly moderated the relation between PTSD symptom severity 
and basal cortisol, a crucial next step may be to investigate whether cortisol changes with sleep 
manipulation.  Investigation of basal cortisol levels pre- and post- treatment for insomnia (e.g., 
Cognitive Behavior Therapy for Insomnia [CBT-I]; Perlis, Jungquist, Smith, & Posner, 2006) 
may implicate clinical pathways in which to target the physiological effects of PTSD.  Similarly, 
investigation of basal cortisol levels pre-and post- treatment for PTSD may elucidate 
directionality of the relationship between PTSD and neuroendocrine reactivity.  Moreover, 
cortisol levels should be compared between individuals with current PTSD to individuals with 
past, but not current PTSD to see if the physiological effects of PTSD remain following 
remittance.   
Lastly, a promising next step in this research would be to examine how basal 
neuroendocrine levels across diagnostic groups are influenced by genomic factors.  Seeing as 
basal stress levels and reactivity are moderately heritable (Steptoe, van Jaarsveld, Semmler, 
Plomin, & Wardle, 2009), examination of shared genetic risk factors seems like an informative 
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future direction for this literature.  The ability to identify individuals with higher biological risk 
for PTSD would allow for targeted prevention and tailored intervention strategies, particularly 
among individuals knowingly entering environments that increase risk for trauma exposure (i.e., 
pre-deployment interventions for veterans).  Although the current literature on the genetics of 
PTSD is not as vastly explored compared to that of other psychiatric phenotypes, examination of 
genetic influences on PTSD has meaningful implications.  The ability to identify genetically at-
risk individuals would allow for targeted prevention and tailored intervention strategies, 
particularly among individuals knowingly entering environments that increase risk for trauma 
exposure (i.e., pre-deployment interventions for veterans).  Additionally, appropriating already 
limited treatment support to those most at risk would better enable effective use of resources 
(Amstadter et al., 2009).  Applying this area of research to target modifiable risk factors (e.g., 
sleep) that cushion the effects of environmental and biologic vulnerability to negative mental 
health outcomes following trauma will have significant clinical implications (Amstadter et al., 
2009).  Examining the biological factors that influence PTSD has meaningful implications.  
 
Conclusions 
The present study aimed to compare baseline neuroendocrine levels by trauma group 
(PTSD, TE, NTC) among a sample of OIF/OEF/OND veterans.  Consistent with the hypotheses, 
basal cortisol levels were marginally significantly different by trauma group, with basal cortisol 
levels in the PTSD being significantly lower than those in the NTC group.  Basal cortisol in the 
TE group did not differ significantly from either the NTC or PTSD groups.  Contrary to the 
hypotheses, no significant effect of trauma group was found for ACTH.  A second, exploratory 
aim was to examine factors that may moderate the relation between PTSD symptom severity and 
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basal neuroendocrine levels.  Sleep disturbance was the only significant moderator of this 
relationship in cortisol, with a greater effect of sleep disturbance on basal cortisol in individuals 
with low levels of PTSD symptom severity, but not in individuals with medium or high levels of 
PTSD symptom severity.  Additionally, lifetime trauma load significantly predicted basal cortisol 
across all models.  No predictive or moderating effects were demonstrated for ACTH.  This study 
enhances the contradictory extant literature by reporting results from a highly standardized study, 
which eliminates methodological confounds that may contribute to inconsistent findings in the 
extant literature.  Differential responses to trauma nod to the complexity of etiological and 
maintaining processes that occur between trauma exposure and the development of subsequent 
psychopathology.  Examining the effects of trauma on basal physiology provides a critical 
stepping ground for future investigations that may inform targeted prevention and intervention 
efforts.  
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